| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | WBP2 BCL9L SRA1 ATN1 NACA SRCAP CREBBP KMT2C ARID1B SNW1 TCERG1 ZMIZ2 FIZ1 SMARCA4 SMARCC2 RERE PRDM16 EP300 MED13 PML | 3.32e-13 | 303 | 157 | 20 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | WBP2 BCL9L SRA1 ATN1 NACA BCORL1 RUNX1T1 CBFA2T3 SRCAP CREBBP HDAC7 SF1 KMT2C ARID1B SNW1 TCERG1 ZMIZ2 FIZ1 SMARCA4 SMARCC2 RERE PRDM16 EP300 MED13 PML | 2.15e-12 | 562 | 157 | 25 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 WBP2 BCL9L ABI1 SRA1 ATN1 SASH1 MAP1A NACA BCORL1 RUNX1T1 CBFA2T3 SRCAP CREBBP HDAC7 SF1 AXIN1 NUFIP1 KMT2C ARID1B SNW1 SHANK2 TCERG1 SNAP91 ZMIZ2 FIZ1 SMARCA4 SMARCC2 GIGYF2 RERE PRDM16 BAG6 EP300 MED13 PML RAB11FIP3 | 7.11e-11 | 1356 | 157 | 36 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 WBP2 BCL9L ABI1 SRA1 ATN1 MAP1A NACA BCORL1 RUNX1T1 CBFA2T3 SRCAP CREBBP HDAC7 SF1 AXIN1 NUFIP1 KMT2C ARID1B SNW1 SHANK2 TCERG1 SNAP91 ZMIZ2 FIZ1 SMARCA4 SMARCC2 RERE PRDM16 EP300 MED13 PML RAB11FIP3 | 8.78e-11 | 1160 | 157 | 33 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription corepressor activity | ATN1 BCORL1 RUNX1T1 CBFA2T3 CREBBP HDAC7 SF1 SNW1 TCERG1 SMARCA4 RERE | 2.05e-06 | 229 | 157 | 11 | GO:0003714 |
| GeneOntologyMolecularFunction | SMAD binding | 5.19e-06 | 86 | 157 | 7 | GO:0046332 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 6.14e-05 | 2 | 157 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 6.14e-05 | 2 | 157 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | transcription factor binding | WBP2 SRA1 PCLO NACA RUNX1T1 CREBBP HDAC7 MLXIPL TAF3 SNW1 TCERG1 KLF1 FIZ1 SMARCA4 PRDM16 EP300 MED13 | 9.33e-05 | 753 | 157 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.83e-04 | 3 | 157 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | WBP2 SRA1 RUNX1T1 CREBBP HDAC7 MLXIPL SNW1 TCERG1 KLF1 FIZ1 SMARCA4 PRDM16 EP300 MED13 | 2.09e-04 | 582 | 157 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | p53 binding | 3.53e-04 | 77 | 157 | 5 | GO:0002039 | |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 3.65e-04 | 4 | 157 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | histone modifying activity | 4.68e-04 | 229 | 157 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 9.46e-04 | 143 | 157 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.27e-03 | 60 | 157 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 WBP11 ABI1 ATN1 SCAF8 SH3BP2 E2F4 CBL CREBBP AXIN1 USP8 SHANK2 SNAP91 KLF1 TRIM9 DMD | 1.48e-03 | 875 | 157 | 16 | GO:0019904 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.67e-03 | 8 | 157 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | WBP2 SRA1 CREBBP MLXIPL SNW1 TCERG1 FIZ1 SMARCA4 EP300 MED13 | 1.74e-03 | 417 | 157 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.09e-03 | 167 | 157 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | chromatin binding | WBP2 SMC4 E2F4 CBFA2T3 CREBBP HDAC7 PHC3 ARID1B TOX4 ZC3H4 SMARCA4 SMARCC2 RERE EP300 | 2.13e-03 | 739 | 157 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 2.14e-03 | 69 | 157 | 4 | GO:0045309 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.19e-03 | 33 | 157 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 2.65e-03 | 10 | 157 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.65e-03 | 10 | 157 | 2 | GO:0140999 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ERF ATN1 SCAF8 NACA BCORL1 MAGEC3 RUNX1T1 RREB1 PTCH1 CBFA2T3 CREBBP HDAC7 SF1 AXIN1 MLXIPL PHC3 TAF3 SNW1 TCERG1 MZF1 ZC3H4 YLPM1 SMARCA4 SMARCC2 RERE HDAC10 ZNF281 PRDM16 EP300 PML | 2.81e-07 | 1399 | 159 | 30 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ERF ATN1 SCAF8 NACA BCORL1 MAGEC3 RUNX1T1 RREB1 PTCH1 CBFA2T3 CREBBP HDAC7 SF1 AXIN1 MLXIPL PHC3 TAF3 SNW1 TCERG1 MZF1 ZC3H4 YLPM1 SMARCA4 SMARCC2 RERE HDAC10 ZNF281 PRDM16 EP300 PML | 3.48e-07 | 1413 | 159 | 30 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ERF ATN1 SCAF8 NACA BCORL1 MAGEC3 RREB1 PTCH1 CBFA2T3 CREBBP HDAC7 MLXIPL TAF3 SNW1 TCERG1 MZF1 YLPM1 SMARCA4 SMARCC2 HDAC10 ZNF281 PRDM16 EP300 | 6.17e-06 | 1053 | 159 | 23 | GO:0000122 |
| GeneOntologyBiologicalProcess | dendrite development | SHANK1 ABI1 ABL2 MAP1A NUMBL SGK1 MINK1 CREBBP ARID1B CELSR2 ARHGAP44 RERE | 1.17e-05 | 335 | 159 | 12 | GO:0016358 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 2.38e-05 | 198 | 159 | 9 | GO:0048813 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.71e-05 | 49 | 159 | 5 | GO:0042771 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 6.03e-05 | 28 | 159 | 4 | GO:0018394 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | WBP2 SPHK2 SETD1B SRCAP CREBBP HDAC7 AXIN1 KMT2C ARID1B KLF1 SMARCA4 SMARCC2 RERE HDAC10 PRDM16 EP300 PML | 6.07e-05 | 741 | 159 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | WBP2 BCL9L SRA1 NACA E2F4 MLXIP RREB1 CREBBP CASZ1 NUFIP1 KMT2C MLXIPL TAF3 SNW1 TCERG1 KLF1 MZF1 ZMIZ2 FIZ1 SMARCA4 PRDM16 EP300 MED13 SMAD1 SERTAD1 | 6.26e-05 | 1390 | 159 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin organization | WBP2 SPHK2 SETD1B BCORL1 SRCAP CREBBP HDAC7 AXIN1 KMT2C ARID1B KLF1 SMARCA4 SMARCC2 RERE HDAC10 PRDM16 BAG6 EP300 PML | 6.32e-05 | 896 | 159 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | WBP2 SPHK2 SETD1B BCORL1 SRCAP CREBBP HDAC7 AXIN1 KMT2C ARID1B TAF3 KLF1 SMARCA4 SMARCC2 RERE HDAC10 PRDM16 BAG6 EP300 PML | 8.83e-05 | 999 | 159 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.45e-04 | 65 | 159 | 5 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.48e-04 | 35 | 159 | 4 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.48e-04 | 35 | 159 | 4 | GO:0030511 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.80e-04 | 68 | 159 | 5 | GO:0141137 | |
| GeneOntologyBiologicalProcess | protein acetylation | 1.80e-04 | 68 | 159 | 5 | GO:0006473 | |
| GeneOntologyBiologicalProcess | protein acylation | 1.91e-04 | 108 | 159 | 6 | GO:0043543 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SHANK1 SEMA3F ABI1 ABL2 MAP1A RAPH1 NUMBL SGK1 MINK1 RREB1 PTCH1 CELSR2 SNAP91 ARHGAP44 RERE DMD EP300 | 2.02e-04 | 819 | 159 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SHANK1 SEMA3F ABI1 ABL2 MAP1A RAPH1 NUMBL SGK1 MINK1 RREB1 PTCH1 CELSR2 SNAP91 ARHGAP44 RERE DMD EP300 | 2.23e-04 | 826 | 159 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 2.34e-04 | 16 | 159 | 3 | GO:0006474 | |
| GeneOntologyBiologicalProcess | protein kinase C signaling | 2.76e-04 | 41 | 159 | 4 | GO:0070528 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 2.82e-04 | 17 | 159 | 3 | GO:0043923 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 2.99e-04 | 276 | 159 | 9 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SHANK1 SEMA3F BCL9L ABI1 ABL2 MAP1A RAPH1 NUMBL SGK1 MINK1 RREB1 PTCH1 FMNL2 CELSR2 SNAP91 ARHGAP44 SMARCA4 FGD1 RERE DMD EP300 | 3.46e-04 | 1194 | 159 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.51e-04 | 4 | 159 | 2 | GO:0018076 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.08e-06 | 140 | 156 | 9 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 5.66e-06 | 171 | 156 | 9 | GO:0034399 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L SETD1B SCAF8 POM121L2 E2F4 MLXIP SRCAP CREBBP HDAC7 SF1 NUFIP1 KMT2C MLXIPL PHC3 ARID1B TAF3 SNW1 AMOTL1 SMARCA4 SMARCC2 RERE HDAC10 SLX4 MED13 SMAD1 | 3.13e-05 | 1377 | 156 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | bBAF complex | 4.71e-05 | 10 | 156 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | dendrite | SHANK1 RIN3 OPN4 ABL2 MAP1A PCLO MINK1 LMTK3 PTCH1 USP8 SHANK2 KCNC3 TRIM9 ARHGAP44 GIGYF2 C4A C4B TANC1 | 7.53e-05 | 858 | 156 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SHANK1 RIN3 OPN4 ABL2 MAP1A PCLO MINK1 LMTK3 PTCH1 USP8 SHANK2 KCNC3 TRIM9 ARHGAP44 GIGYF2 C4A C4B TANC1 | 7.76e-05 | 860 | 156 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | npBAF complex | 1.40e-04 | 14 | 156 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | postsynaptic density | SHANK1 LRFN1 ABI1 MAP1A PCLO MINK1 USP8 SHANK2 SNAP91 ARHGAP44 TANC1 DMD | 1.50e-04 | 451 | 156 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | nBAF complex | 2.13e-04 | 16 | 156 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | asymmetric synapse | SHANK1 LRFN1 ABI1 MAP1A PCLO MINK1 USP8 SHANK2 SNAP91 ARHGAP44 TANC1 DMD | 2.51e-04 | 477 | 156 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | somatodendritic compartment | SHANK1 RIN3 OPN4 ABL2 MAP1A PCLO MINK1 LMTK3 PTCH1 USP8 SHANK2 SNAP91 KCNC3 TRIM9 ARHGAP44 GIGYF2 C4A C4B TANC1 DMD FCHSD1 | 3.24e-04 | 1228 | 156 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic specialization | SHANK1 LRFN1 ABI1 MAP1A PCLO MINK1 USP8 SHANK2 SNAP91 ARHGAP44 TANC1 DMD | 4.05e-04 | 503 | 156 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | SHANK1 LRFN1 ABI1 MAP1A PCLO MINK1 USP8 SHANK2 SNAP91 ARHGAP44 TANC1 DMD | 5.73e-04 | 523 | 156 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | chromatin | WBP2 SPHK2 ERF E2F4 MLXIP SRCAP CREBBP CASZ1 NUFIP1 MLXIPL ARID1B TOX4 SNW1 KLF1 ZMIZ2 FIZ1 SMARCA4 ZFHX2 SMARCC2 DMRTA1 EP300 SLX4 SMAD1 | 6.37e-04 | 1480 | 156 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | presynaptic active zone | 6.72e-04 | 141 | 156 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | Weibel-Palade body | 8.14e-04 | 6 | 156 | 2 | GO:0033093 | |
| GeneOntologyCellularComponent | axon | RIN3 ABI1 OPN4 MAP1A PCLO MINK1 LMTK3 PTCH1 CBL SHANK2 SNAP91 KCNC3 C4A C4B TANC1 DMD | 1.04e-03 | 891 | 156 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.43e-03 | 30 | 156 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 1.50e-03 | 8 | 156 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.50e-03 | 8 | 156 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.92e-03 | 9 | 156 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | SMAD protein complex | 2.39e-03 | 10 | 156 | 2 | GO:0071141 | |
| HumanPheno | Abnormal midface morphology | WBP11 SETD1B ERF SOBP DHX37 SH3BP2 PCLO RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 KMT2C MLXIPL ARID1B FGD1 RERE PRDM16 HCCS EP300 | 5.47e-06 | 704 | 55 | 21 | HP:0000309 |
| HumanPheno | Hypoplasia of the phalanges of the toes | 5.65e-06 | 12 | 55 | 4 | HP:0010746 | |
| HumanPheno | Hypospadias | DHX37 RREB1 SRCAP CREBBP CASZ1 ARID1B KLF1 SMARCA4 FGD1 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 | 6.35e-06 | 377 | 55 | 15 | HP:0000047 |
| HumanPheno | Displacement of the urethral meatus | DHX37 RREB1 SRCAP CREBBP CASZ1 ARID1B KLF1 SMARCA4 FGD1 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 | 1.20e-05 | 397 | 55 | 15 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | DHX37 RREB1 SRCAP CREBBP CASZ1 ARID1B KLF1 SMARCA4 FGD1 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 | 1.27e-05 | 399 | 55 | 15 | HP:0032076 |
| HumanPheno | Hirsutism | H6PD SRCAP CREBBP CASZ1 USP8 ARID1B SMARCA4 SMARCC2 RERE PRDM16 EP300 | 1.42e-05 | 216 | 55 | 11 | HP:0001007 |
| HumanPheno | Abnormality of the urethra | DHX37 RREB1 SRCAP CREBBP CASZ1 MLXIPL ARID1B KLF1 SMARCA4 FGD1 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 | 1.86e-05 | 465 | 55 | 16 | HP:0000795 |
| HumanPheno | Tetralogy of Fallot | RREB1 PTCH1 SRCAP CASZ1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 SLX4 | 2.21e-05 | 185 | 55 | 10 | HP:0001636 |
| HumanPheno | Bifid ribs | 2.61e-05 | 17 | 55 | 4 | HP:0000892 | |
| HumanPheno | Long philtrum | ERF ATN1 PCLO RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 MLXIPL ARID1B SMARCA4 FGD1 RERE PRDM16 | 3.03e-05 | 429 | 55 | 15 | HP:0000343 |
| HumanPheno | Short 5th finger | 5.55e-05 | 64 | 55 | 6 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 6.62e-05 | 66 | 55 | 6 | HP:0006262 | |
| HumanPheno | Choanal atresia or stenosis | 7.99e-05 | 134 | 55 | 8 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 7.99e-05 | 134 | 55 | 8 | HP:0000415 | |
| HumanPheno | Abnormal hair morphology | WBP11 SRA1 SETD1B ERF SASH1 DHX37 BCORL1 H6PD RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 KMT2C USP8 MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 C4A C4B RERE PRDM16 HCCS EP300 SLX4 MED13 | 8.48e-05 | 1424 | 55 | 29 | HP:0001595 |
| HumanPheno | Abnormal earlobe morphology | 9.35e-05 | 137 | 55 | 8 | HP:0000363 | |
| HumanPheno | Plantar crease between first and second toes | 1.14e-04 | 2 | 55 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.14e-04 | 2 | 55 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.14e-04 | 2 | 55 | 2 | HP:0001042 | |
| HumanPheno | Hypertrichosis | WBP11 H6PD PTCH1 SRCAP CREBBP CASZ1 USP8 ARID1B SMARCA4 SMARCC2 RERE PRDM16 EP300 MED13 | 1.15e-04 | 425 | 55 | 14 | HP:0000998 |
| HumanPheno | Impairment in personality functioning | WBP11 SETD1B BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C USP8 MLXIPL ARID1B RBM12 SMARCA4 FGD1 SMARCC2 GIGYF2 DLST C4A C4B RERE PRDM16 EP300 MED13 | 1.18e-04 | 1141 | 55 | 25 | HP:0031466 |
| HumanPheno | Abnormality of the philtrum | ERF ATN1 DHX37 PCLO RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 RERE PRDM16 EP300 MED13 | 1.19e-04 | 726 | 55 | 19 | HP:0000288 |
| HumanPheno | Patent ductus arteriosus | ERF RREB1 CBL CREBBP CASZ1 AXIN1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 EP300 SLX4 | 1.54e-04 | 382 | 55 | 13 | HP:0001643 |
| HumanPheno | Abnormal hair quantity | WBP11 SRA1 SASH1 DHX37 BCORL1 H6PD PTCH1 SRCAP CBL CREBBP CASZ1 USP8 ARID1B SMARCA4 SMARCC2 C4A C4B RERE PRDM16 EP300 MED13 | 1.96e-04 | 888 | 55 | 21 | HP:0011362 |
| HumanPheno | Abnormality of dental eruption | SH3BP2 PTCH1 SRCAP CREBBP KMT2C ARID1B SMARCA4 FGD1 SMARCC2 EP300 | 2.01e-04 | 240 | 55 | 10 | HP:0006292 |
| HumanPheno | Wide nasal base | 2.06e-04 | 28 | 55 | 4 | HP:0012810 | |
| HumanPheno | Reduced impulse control | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CBL CREBBP CASZ1 KMT2C MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 GIGYF2 C4A C4B RERE PRDM16 EP300 MED13 PML | 2.06e-04 | 1032 | 55 | 23 | HP:5200045 |
| HumanPheno | Midface retrusion | ERF DHX37 PTCH1 CBL CASZ1 KMT2C MLXIPL FGD1 RERE PRDM16 HCCS | 2.19e-04 | 291 | 55 | 11 | HP:0011800 |
| HumanPheno | Narrow nasal bridge | 2.36e-04 | 53 | 55 | 5 | HP:0000446 | |
| HumanPheno | Abnormal epididymis morphology | 2.71e-04 | 30 | 55 | 4 | HP:0009714 | |
| HumanPheno | Abnormal nasal base norphology | 2.71e-04 | 30 | 55 | 4 | HP:0012808 | |
| HumanPheno | Panic attack | 2.81e-04 | 55 | 55 | 5 | HP:0025269 | |
| HumanPheno | Abnormal penis morphology | SRA1 DHX37 RREB1 PTCH1 SRCAP CREBBP CASZ1 MLXIPL ARID1B KLF1 SMARCA4 FGD1 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 | 3.02e-04 | 712 | 55 | 18 | HP:0000036 |
| HumanPheno | Non-epileptic seizure | 3.07e-04 | 56 | 55 | 5 | HP:0033052 | |
| HumanPheno | Choanal atresia | 3.13e-04 | 123 | 55 | 7 | HP:0000453 | |
| HumanPheno | Reduced attention regulation | WBP11 ERF SOBP BCORL1 RREB1 PTCH1 SRCAP GABBR2 CBL CREBBP MLXIPL FGD1 RERE EP300 MED13 | 3.13e-04 | 526 | 55 | 15 | HP:5200044 |
| HumanPheno | Abnormal duodenum morphology | 3.29e-04 | 88 | 55 | 6 | HP:0002246 | |
| HumanPheno | Congenital malformation of the great arteries | ERF RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 AXIN1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 EP300 SLX4 | 3.33e-04 | 529 | 55 | 15 | HP:0011603 |
| HumanPheno | Laryngeal cartilage malformation | 3.41e-04 | 3 | 55 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 3.41e-04 | 3 | 55 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 3.41e-04 | 3 | 55 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 3.41e-04 | 3 | 55 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 3.41e-04 | 3 | 55 | 2 | HP:0005322 | |
| HumanPheno | Short phalanx of the 5th toe | 3.41e-04 | 3 | 55 | 2 | HP:0100368 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 3.41e-04 | 3 | 55 | 2 | HP:0005895 | |
| HumanPheno | Recurrent maladaptive behavior | WBP11 SETD1B BCORL1 RREB1 PTCH1 SRCAP GABBR2 CBL CREBBP CASZ1 KMT2C USP8 MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 GIGYF2 DLST C4A C4B RERE PRDM16 EP300 MED13 PML | 3.46e-04 | 1293 | 55 | 26 | HP:5200241 |
| HumanPheno | Complex cardiac malformations | RREB1 PTCH1 SRCAP CASZ1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 SLX4 | 3.50e-04 | 257 | 55 | 10 | HP:0002565 |
| HumanPheno | Hypoplastic fifth fingernail | 3.99e-04 | 14 | 55 | 3 | HP:0008398 | |
| HumanPheno | macules | 4.08e-04 | 262 | 55 | 10 | HP:0200031 | |
| HumanPheno | Conotruncal defect | RREB1 PTCH1 SRCAP CASZ1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 SLX4 | 4.34e-04 | 264 | 55 | 10 | HP:0001710 |
| HumanPheno | Abnormally increased volition | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C MLXIPL ARID1B RBM12 SMARCA4 FGD1 SMARCC2 GIGYF2 RERE PRDM16 EP300 MED13 | 4.38e-04 | 869 | 55 | 20 | HP:5200263 |
| HumanPheno | Abnormal morphology of the great vessels | ERF ATN1 RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 AXIN1 MLXIPL ARID1B SMARCA4 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 | 4.57e-04 | 736 | 55 | 18 | HP:0030962 |
| HumanPheno | Disinhibition | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 GIGYF2 RERE PRDM16 EP300 MED13 | 4.87e-04 | 807 | 55 | 19 | HP:0000734 |
| HumanPheno | Inappropriate behavior | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 GIGYF2 RERE PRDM16 EP300 MED13 | 4.87e-04 | 807 | 55 | 19 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 GIGYF2 RERE PRDM16 EP300 MED13 | 4.87e-04 | 807 | 55 | 19 | HP:5200123 |
| HumanPheno | Social disinhibition | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 GIGYF2 RERE PRDM16 EP300 MED13 | 4.87e-04 | 807 | 55 | 19 | HP:5200029 |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 5.55e-04 | 36 | 55 | 4 | HP:0010173 | |
| HumanPheno | Neoplasm of the central nervous system | 5.67e-04 | 178 | 55 | 8 | HP:0100006 | |
| HumanPheno | Thick lower lip vermilion | 5.77e-04 | 136 | 55 | 7 | HP:0000179 | |
| HumanPheno | Hyperactivity | WBP11 BCORL1 RREB1 PTCH1 SRCAP GABBR2 CREBBP MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 RERE EP300 MED13 | 5.94e-04 | 558 | 55 | 15 | HP:0000752 |
| HumanPheno | Square face | 6.04e-04 | 16 | 55 | 3 | HP:0000321 | |
| HumanPheno | Abnormality of skin pigmentation | WBP11 ERF SASH1 RREB1 PTCH1 CBL CREBBP CASZ1 USP8 MLXIPL RERE PRDM16 HCCS EP300 SLX4 | 6.29e-04 | 561 | 55 | 15 | HP:0001000 |
| HumanPheno | Trichiasis | 6.77e-04 | 4 | 55 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 6.77e-04 | 4 | 55 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 6.77e-04 | 4 | 55 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 6.77e-04 | 4 | 55 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 6.77e-04 | 4 | 55 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 6.77e-04 | 4 | 55 | 2 | HP:0031207 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 6.77e-04 | 4 | 55 | 2 | HP:0010343 | |
| HumanPheno | Abnormal ventriculoarterial connection | RREB1 PTCH1 SRCAP CASZ1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 SLX4 | 6.91e-04 | 280 | 55 | 10 | HP:0011563 |
| HumanPheno | Immunologic hypersensitivity | 7.10e-04 | 231 | 55 | 9 | HP:0100326 | |
| HumanPheno | Prominent eyelashes | 7.28e-04 | 17 | 55 | 3 | HP:0011231 | |
| HumanPheno | Oral aversion | 7.28e-04 | 17 | 55 | 3 | HP:0012523 | |
| HumanPheno | Abnormal cheek morphology | WBP11 SETD1B SH3BP2 PCLO CREBBP MLXIPL ARID1B FGD1 RERE EP300 | 7.31e-04 | 282 | 55 | 10 | HP:0004426 |
| HumanPheno | Wide nasal bridge | ERF RREB1 PTCH1 SRCAP CREBBP CASZ1 ARID1B SMARCA4 FGD1 RERE PRDM16 HCCS EP300 MED13 | 7.40e-04 | 508 | 55 | 14 | HP:0000431 |
| HumanPheno | Abnormal 5th finger morphology | ERF SRCAP CBL CREBBP CASZ1 MLXIPL ARID1B SMARCA4 FGD1 SMARCC2 RERE PRDM16 EP300 SLX4 | 7.55e-04 | 509 | 55 | 14 | HP:0004207 |
| HumanPheno | Abnormal connection of the cardiac segments | RREB1 PTCH1 SRCAP CASZ1 ARID1B SMARCA4 SMARCC2 RERE PRDM16 SLX4 | 7.73e-04 | 284 | 55 | 10 | HP:0011545 |
| HumanPheno | Macule | 7.79e-04 | 234 | 55 | 9 | HP:0012733 | |
| HumanPheno | Aggressive behavior | BCORL1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C ARID1B SMARCA4 SMARCC2 GIGYF2 RERE PRDM16 EP300 | 8.66e-04 | 516 | 55 | 14 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | BCORL1 PTCH1 SRCAP GABBR2 CREBBP CASZ1 KMT2C ARID1B SMARCA4 SMARCC2 GIGYF2 RERE PRDM16 EP300 | 8.66e-04 | 516 | 55 | 14 | HP:0006919 |
| HumanPheno | Short attention span | WBP11 SOBP BCORL1 RREB1 PTCH1 SRCAP GABBR2 CBL CREBBP MLXIPL FGD1 RERE EP300 MED13 | 8.83e-04 | 517 | 55 | 14 | HP:0000736 |
| HumanPheno | Cryptorchidism | PLVAP SRA1 ATN1 DHX37 RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 ARID1B SMARCA4 FGD1 SMARCC2 RERE PRDM16 EP300 SLX4 | 9.32e-04 | 780 | 55 | 18 | HP:0000028 |
| HumanPheno | Abnormal aortic morphology | ATN1 RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 RERE PRDM16 HCCS EP300 SLX4 | 9.34e-04 | 401 | 55 | 12 | HP:0001679 |
| HumanPheno | Abnormal lower lip morphology | 9.92e-04 | 242 | 55 | 9 | HP:0000178 | |
| HumanPheno | Impulsivity | 9.94e-04 | 149 | 55 | 7 | HP:0100710 | |
| HumanPheno | Abnormality of the hairline | WBP11 SRCAP CBL CREBBP ARID1B SMARCA4 FGD1 SMARCC2 RERE EP300 | 1.01e-03 | 294 | 55 | 10 | HP:0009553 |
| HumanPheno | Hypoplastic fifth toenail | 1.02e-03 | 19 | 55 | 3 | HP:0011937 | |
| HumanPheno | Abnormal aortic arch morphology | 1.03e-03 | 109 | 55 | 6 | HP:0012303 | |
| HumanPheno | Neoplasm of the nervous system | 1.03e-03 | 195 | 55 | 8 | HP:0004375 | |
| HumanPheno | Abnormal cardiac septum morphology | WBP11 ATN1 RREB1 SRCAP CBL CREBBP CASZ1 AXIN1 MLXIPL ARID1B SMARCA4 SMARCC2 RERE PRDM16 HCCS EP300 SLX4 MYBPC3 | 1.04e-03 | 787 | 55 | 18 | HP:0001671 |
| HumanPheno | Abnormality of the anus | 1.11e-03 | 246 | 55 | 9 | HP:0004378 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.12e-03 | 5 | 55 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.12e-03 | 5 | 55 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.12e-03 | 5 | 55 | 2 | HP:0030421 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 1.12e-03 | 5 | 55 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 1.12e-03 | 5 | 55 | 2 | HP:0010342 | |
| HumanPheno | Abnormal consumption behavior | 1.15e-03 | 299 | 55 | 10 | HP:0040202 | |
| HumanPheno | Thick eyebrow | 1.21e-03 | 154 | 55 | 7 | HP:0000574 | |
| HumanPheno | Abnormal vascular morphology | VWF ERF ATN1 RREB1 PTCH1 SRCAP CBL CREBBP CASZ1 AXIN1 USP8 MLXIPL ARID1B SMARCA4 SMARCC2 DLST C4A RERE DMD PRDM16 HCCS EP300 SLX4 PML MYBPC3 | 1.26e-03 | 1319 | 55 | 25 | HP:0025015 |
| HumanPheno | Prominent lips | 1.30e-03 | 156 | 55 | 7 | HP:0000184 | |
| Domain | Nuc_rcpt_coact_CREBbp | 6.67e-05 | 2 | 153 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 6.67e-05 | 2 | 153 | 2 | SM00551 | |
| Domain | Atrophin-like | 6.67e-05 | 2 | 153 | 2 | IPR002951 | |
| Domain | - | 6.67e-05 | 2 | 153 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 6.67e-05 | 2 | 153 | 2 | IPR010303 | |
| Domain | - | 6.67e-05 | 2 | 153 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 6.67e-05 | 2 | 153 | 2 | PF09030 | |
| Domain | zf-TAZ | 6.67e-05 | 2 | 153 | 2 | PF02135 | |
| Domain | ZF_TAZ | 6.67e-05 | 2 | 153 | 2 | PS50134 | |
| Domain | KAT11 | 6.67e-05 | 2 | 153 | 2 | SM01250 | |
| Domain | Znf_TAZ | 6.67e-05 | 2 | 153 | 2 | IPR000197 | |
| Domain | KIX | 6.67e-05 | 2 | 153 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 6.67e-05 | 2 | 153 | 2 | PF08214 | |
| Domain | KIX | 6.67e-05 | 2 | 153 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 6.67e-05 | 2 | 153 | 2 | IPR031162 | |
| Domain | DUF902 | 6.67e-05 | 2 | 153 | 2 | PF06001 | |
| Domain | - | 6.67e-05 | 2 | 153 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 6.67e-05 | 2 | 153 | 2 | IPR013178 | |
| Domain | KIX_dom | 6.67e-05 | 2 | 153 | 2 | IPR003101 | |
| Domain | Atrophin-1 | 6.67e-05 | 2 | 153 | 2 | PF03154 | |
| Domain | CBP_P300_HAT | 6.67e-05 | 2 | 153 | 2 | PS51727 | |
| Domain | NHR2 | 1.99e-04 | 3 | 153 | 2 | PF08788 | |
| Domain | CBFA2T1/2/3 | 1.99e-04 | 3 | 153 | 2 | IPR013289 | |
| Domain | NHR2 | 1.99e-04 | 3 | 153 | 2 | IPR014896 | |
| Domain | FH2 | 2.28e-04 | 15 | 153 | 3 | PS51444 | |
| Domain | FH2_Formin | 2.28e-04 | 15 | 153 | 3 | IPR015425 | |
| Domain | FH2 | 2.28e-04 | 15 | 153 | 3 | PF02181 | |
| Domain | FH2 | 2.28e-04 | 15 | 153 | 3 | SM00498 | |
| Domain | SAM_1 | 2.38e-04 | 68 | 153 | 5 | PF00536 | |
| Domain | HSA | 3.96e-04 | 4 | 153 | 2 | SM00573 | |
| Domain | HSA | 3.96e-04 | 4 | 153 | 2 | PS51204 | |
| Domain | HSA_dom | 3.96e-04 | 4 | 153 | 2 | IPR014012 | |
| Domain | HSA | 3.96e-04 | 4 | 153 | 2 | PF07529 | |
| Domain | ZF_ZZ_2 | 4.02e-04 | 18 | 153 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.02e-04 | 18 | 153 | 3 | PS01357 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.02e-04 | 18 | 153 | 3 | IPR008930 | |
| Domain | ZZ | 4.02e-04 | 18 | 153 | 3 | PF00569 | |
| Domain | Znf_ZZ | 4.74e-04 | 19 | 153 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 4.74e-04 | 19 | 153 | 3 | SM00291 | |
| Domain | TAFH | 6.56e-04 | 5 | 153 | 2 | SM00549 | |
| Domain | Anaphylatoxin_comp_syst | 6.56e-04 | 5 | 153 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 6.56e-04 | 5 | 153 | 2 | IPR001840 | |
| Domain | TAFH_NHR1 | 6.56e-04 | 5 | 153 | 2 | IPR003894 | |
| Domain | TAFH | 6.56e-04 | 5 | 153 | 2 | PS51119 | |
| Domain | TAFH | 6.56e-04 | 5 | 153 | 2 | PF07531 | |
| Domain | SH3_2 | 7.06e-04 | 86 | 153 | 5 | PF07653 | |
| Domain | SH3_2 | 7.06e-04 | 86 | 153 | 5 | IPR011511 | |
| Domain | SAM | 7.84e-04 | 88 | 153 | 5 | SM00454 | |
| Domain | Nuc_rcpt_coact | 9.79e-04 | 6 | 153 | 2 | IPR009110 | |
| Domain | OSR1_C | 9.79e-04 | 6 | 153 | 2 | PF12202 | |
| Domain | ZF_FCS | 9.79e-04 | 6 | 153 | 2 | PS51024 | |
| Domain | Kinase_OSR1/WNK_CCT | 9.79e-04 | 6 | 153 | 2 | IPR024678 | |
| Domain | SAM_DOMAIN | 1.11e-03 | 95 | 153 | 5 | PS50105 | |
| Domain | SAM | 1.22e-03 | 97 | 153 | 5 | IPR001660 | |
| Domain | Bromodomain_CS | 1.22e-03 | 26 | 153 | 3 | IPR018359 | |
| Domain | - | 1.22e-03 | 26 | 153 | 3 | 1.25.40.90 | |
| Domain | ANATO | 1.36e-03 | 7 | 153 | 2 | SM00104 | |
| Domain | RNA_pol_II-bd | 1.36e-03 | 7 | 153 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.36e-03 | 7 | 153 | 2 | PF04818 | |
| Domain | ANAPHYLATOXIN_2 | 1.36e-03 | 7 | 153 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.36e-03 | 7 | 153 | 2 | PS01177 | |
| Domain | ANATO | 1.36e-03 | 7 | 153 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.36e-03 | 7 | 153 | 2 | IPR000020 | |
| Domain | AT_hook | 1.36e-03 | 27 | 153 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.36e-03 | 27 | 153 | 3 | IPR017956 | |
| Domain | ENTH_VHS | 1.68e-03 | 29 | 153 | 3 | IPR008942 | |
| Domain | - | 1.80e-03 | 106 | 153 | 5 | 1.10.150.50 | |
| Domain | RPR | 1.81e-03 | 8 | 153 | 2 | SM00582 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.81e-03 | 8 | 153 | 2 | IPR019565 | |
| Domain | CID_dom | 1.81e-03 | 8 | 153 | 2 | IPR006569 | |
| Domain | Thiol-ester_cl | 1.81e-03 | 8 | 153 | 2 | PF10569 | |
| Domain | CID | 1.81e-03 | 8 | 153 | 2 | PS51391 | |
| Domain | MacrogloblnA2_CS | 1.81e-03 | 8 | 153 | 2 | IPR019742 | |
| Domain | SH3 | 2.05e-03 | 216 | 153 | 7 | SM00326 | |
| Domain | SH3 | 2.05e-03 | 216 | 153 | 7 | PS50002 | |
| Domain | SH3_domain | 2.27e-03 | 220 | 153 | 7 | IPR001452 | |
| Domain | Drf_GBD | 2.31e-03 | 9 | 153 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.31e-03 | 9 | 153 | 2 | PF06367 | |
| Domain | FH3_dom | 2.31e-03 | 9 | 153 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.31e-03 | 9 | 153 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 2.31e-03 | 9 | 153 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.31e-03 | 9 | 153 | 2 | SM01140 | |
| Domain | SAM/pointed | 2.77e-03 | 117 | 153 | 5 | IPR013761 | |
| Domain | A2M | 2.87e-03 | 10 | 153 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.87e-03 | 10 | 153 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.87e-03 | 10 | 153 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.87e-03 | 10 | 153 | 2 | PF07677 | |
| Domain | A2M_comp | 2.87e-03 | 10 | 153 | 2 | PF07678 | |
| Domain | A2M_N | 2.87e-03 | 10 | 153 | 2 | PF01835 | |
| Domain | A2M_N | 2.87e-03 | 10 | 153 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.87e-03 | 10 | 153 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.87e-03 | 10 | 153 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.87e-03 | 10 | 153 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.87e-03 | 10 | 153 | 2 | IPR001599 | |
| Domain | BROMODOMAIN_1 | 3.42e-03 | 37 | 153 | 3 | PS00633 | |
| Domain | GBD/FH3_dom | 3.49e-03 | 11 | 153 | 2 | IPR014768 | |
| Domain | Hist_deacetyl | 3.49e-03 | 11 | 153 | 2 | PF00850 | |
| Domain | GBD_FH3 | 3.49e-03 | 11 | 153 | 2 | PS51232 | |
| Domain | - | 3.49e-03 | 11 | 153 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse_dom | 3.49e-03 | 11 | 153 | 2 | IPR023801 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 8.24e-06 | 37 | 107 | 5 | M27797 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | SETD1B CREBBP AXIN1 KMT2C PHC3 ARID1B SMARCA4 SMARCC2 EP300 PML | 1.26e-05 | 237 | 107 | 10 | M27786 |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.07e-05 | 22 | 107 | 4 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.97e-05 | 24 | 107 | 4 | M13404 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.03e-05 | 48 | 107 | 5 | M611 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.58e-05 | 28 | 107 | 4 | M6177 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 6.44e-05 | 29 | 107 | 4 | M48076 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 7.63e-05 | 58 | 107 | 5 | M29616 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 8.43e-05 | 31 | 107 | 4 | M39522 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.22e-04 | 34 | 107 | 4 | MM15531 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.32e-04 | 65 | 107 | 5 | M39682 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.46e-04 | 14 | 107 | 3 | M27808 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.81e-04 | 15 | 107 | 3 | MM1439 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.22e-04 | 16 | 107 | 3 | M27121 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.22e-04 | 16 | 107 | 3 | M8516 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | SETD1B CREBBP KMT2C ARID1B SMARCA4 SMARCC2 HDAC10 PRDM16 EP300 | 2.24e-04 | 272 | 107 | 9 | M29619 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.44e-04 | 74 | 107 | 5 | M616 | |
| Pathway | PID_REG_GR_PATHWAY | 3.94e-04 | 82 | 107 | 5 | M115 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.35e-04 | 47 | 107 | 4 | M7946 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.41e-04 | 20 | 107 | 3 | M27881 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 4.71e-04 | 301 | 107 | 9 | MM15983 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 5.12e-04 | 21 | 107 | 3 | M39593 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.62e-04 | 5 | 107 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 5.62e-04 | 5 | 107 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 5.62e-04 | 5 | 107 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 5.62e-04 | 5 | 107 | 2 | M27228 | |
| Pathway | PID_AR_TF_PATHWAY | 6.90e-04 | 53 | 107 | 4 | M151 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 8.39e-04 | 6 | 107 | 2 | M22062 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.66e-04 | 25 | 107 | 3 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 9.73e-04 | 26 | 107 | 3 | M2499 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.73e-04 | 26 | 107 | 3 | MM14793 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.09e-03 | 153 | 107 | 6 | MM15522 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.17e-03 | 7 | 107 | 2 | MM1573 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.17e-03 | 7 | 107 | 2 | MM14685 | |
| Pathway | PID_RB_1PATHWAY | 1.49e-03 | 65 | 107 | 4 | M279 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.49e-03 | 110 | 107 | 5 | M48259 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.55e-03 | 8 | 107 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.55e-03 | 8 | 107 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.55e-03 | 8 | 107 | 2 | M48024 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.55e-03 | 8 | 107 | 2 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.55e-03 | 8 | 107 | 2 | M27031 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.55e-03 | 8 | 107 | 2 | M46443 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.58e-03 | 66 | 107 | 4 | M101 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.80e-03 | 32 | 107 | 3 | M39521 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L ERF ATN1 SOBP BCORL1 FBRSL1 RREB1 CREBBP KMT2C ARID1B TAF3 ZMIZ2 SMARCA4 SMARCC2 RERE ZNF281 PRDM16 EP300 SLX4 | 5.19e-15 | 351 | 162 | 19 | 38297188 |
| Pubmed | BCL9L WBP11 ERF ATN1 SOBP SCAF8 DHX37 NACA BCORL1 FBRSL1 RREB1 SRCAP CREBBP KMT2C PHC3 ARID1B MAP7D1 TAF3 RBM12 SNW1 TCERG1 TRIM9 ZMIZ2 YLPM1 SMARCA4 SMARCC2 GIGYF2 RERE ZNF281 PRDM16 EP300 SLX4 PML | 2.11e-14 | 1429 | 162 | 33 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F SPHK2 RIN3 LRFN1 SETD1B FBRSL1 MLXIP PTCH1 SRCAP HDAC7 CASZ1 C2CD2L PKMYT1 NHSL1 KMT2C SHANK2 CELSR2 INF2 ZMIZ2 ARHGAP44 NAV2 TANC1 ZNF579 PRDM16 EP300 MED13 WNK2 RAB11FIP3 | 2.83e-13 | 1105 | 162 | 28 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PHACTR2 ABI1 ABL2 SASH1 TTC28 RAPH1 NUMBL MINK1 FAM98A MLXIP CBL HDAC7 NHSL1 USP8 MLXIPL MAP7D1 TCERG1 CASKIN2 TRIM9 KIAA1217 NAV2 GIGYF2 TANC1 WNK4 PML | 3.17e-13 | 861 | 162 | 25 | 36931259 |
| Pubmed | WBP2 TTC28 RAPH1 SMC4 SRCAP CBL CREBBP KMT2C ARID1B TAF3 TOX4 SNW1 TCERG1 AMOTL1 YLPM1 SMARCA4 GIGYF2 NAA30 EP300 | 1.40e-11 | 549 | 162 | 19 | 38280479 | |
| Pubmed | ERF ATN1 MAP1A TTC28 SH3BP2 FBRSL1 RREB1 SRCAP FMNL2 CREBBP NUFIP1 C2CD2L ARID1B MAP7D1 TAF3 ZC3H4 FIZ1 SMARCA4 SMARCC2 TANC1 RERE ZNF579 ZNF281 PRDM16 EP300 PML | 1.42e-11 | 1116 | 162 | 26 | 31753913 | |
| Pubmed | SHANK1 CPEB2 ABI1 VWF MAP1A NUMBL PRR36 PCLO MINK1 FAM98A FMNL2 NHSL1 MLXIPL MAP7D1 SHANK2 SNAP91 INF2 TRIM9 KIAA1217 ARHGAP44 SMARCA4 PPP1R18 SMARCC2 DLST C4A C4B TANC1 DMD WNK2 | 2.36e-11 | 1431 | 162 | 29 | 37142655 | |
| Pubmed | BCL9L CHERP ATN1 CREBBP CASZ1 ARID1B RBM12 ZC3H4 YLPM1 SMARCA4 SMARCC2 RERE ZNF281 MED13 | 3.70e-11 | 268 | 162 | 14 | 33640491 | |
| Pubmed | SHANK1 CBLL1 WBP11 LRFN1 ABI1 NUMBL PRR36 MINK1 LMTK3 GABBR2 MAP7D1 SNW1 SHANK2 CELSR2 SNAP91 ZC3H4 KIAA1217 ARHGAP44 YLPM1 SMARCA4 SMARCC2 GIGYF2 WNK2 | 1.49e-10 | 963 | 162 | 23 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATN1 RAPH1 CARHSP1 SCAF8 MINK1 RREB1 HDAC7 SF1 PHC3 TAF3 ZC3H4 YLPM1 SMARCA4 PPP1R18 SMARCC2 GIGYF2 RERE ZNF579 BAG6 MED13 | 6.78e-10 | 774 | 162 | 20 | 15302935 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ERF PCLO BCORL1 FBRSL1 RREB1 CREBBP CASZ1 KMT2C PHC3 ARID1B ZMIZ2 SMARCA4 SMARCC2 PRDM16 EP300 | 6.88e-10 | 398 | 162 | 15 | 35016035 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CBLL1 WBP11 CHERP BCORL1 FAM98A RREB1 SF1 PHC3 ARID1B TAF3 TOX4 SNW1 TCERG1 SNAP91 ZC3H4 YLPM1 SMARCA4 SMARCC2 GIGYF2 ZNF281 SLX4 PML | 7.43e-10 | 954 | 162 | 22 | 36373674 |
| Pubmed | SHANK1 VWF ABL2 MAP1A CBL FMNL2 CREBBP KMT2C TOX4 TCERG1 NAV2 GIGYF2 C4A DMD EP300 WNK2 | 1.28e-09 | 486 | 162 | 16 | 20936779 | |
| Pubmed | WBP11 PHACTR2 ABI1 CHERP RAPH1 SRCAP SF1 SNW1 TCERG1 INF2 TRIM9 ZC3H4 YLPM1 SMARCA4 SMARCC2 DLST | 2.27e-09 | 506 | 162 | 16 | 30890647 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CHERP MAP1A RAPH1 NUMBL NACA SRCAP SF1 USP8 PHC3 TOX4 RBM12 SNW1 TCERG1 TRIM9 ZC3H4 KIAA1217 YLPM1 SMARCA4 GIGYF2 ZNF281 PML | 2.92e-09 | 934 | 162 | 21 | 33916271 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.14e-09 | 154 | 162 | 10 | 16055720 | |
| Pubmed | SETD1B SRCAP CREBBP HDAC7 PHC3 ARID1B SMARCA4 SMARCC2 HDAC10 EP300 | 3.78e-09 | 157 | 162 | 10 | 30186101 | |
| Pubmed | CBLL1 BCL9L WBP11 TTC28 SMC4 ZNF524 KMT2C TAF3 SNW1 ZC3H4 SMARCA4 SMARCC2 ZNF281 BAG6 PML | 6.34e-09 | 469 | 162 | 15 | 27634302 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PHACTR2 ABI1 RAPH1 NUMBL MINK1 CBL FMNL2 NHSL1 USP8 SHANK2 CASKIN2 KIAA1217 NAV2 PPP1R18 GIGYF2 TANC1 | 1.08e-08 | 565 | 162 | 16 | 25468996 |
| Pubmed | WBP11 ERF ATN1 TTC28 SCAF8 DHX37 MINK1 NACA FBRSL1 MAP7D1 TCERG1 CASKIN2 ZC3H4 GIGYF2 C4A C4B TANC1 | 1.18e-08 | 650 | 162 | 17 | 38777146 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | WBP2 CDIP1 ATN1 SPATA31E1 MAP1A TSC22D2 LMTK3 PTCH1 PHC3 ZMIZ2 YLPM1 WNK4 WNK2 SMAD1 | 1.66e-08 | 430 | 162 | 14 | 35044719 |
| Pubmed | 4.38e-08 | 152 | 162 | 9 | 38360978 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 9.32e-08 | 10 | 162 | 4 | 16751102 | |
| Pubmed | ABI1 ABL2 MAP1A NUMBL PCLO MINK1 LMTK3 C2CD2L SHANK2 SNAP91 PRRT3 GIGYF2 | 9.49e-08 | 347 | 162 | 12 | 17114649 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 10673036 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 10347196 | ||
| Pubmed | WBP2 PHACTR2 ABI1 ABL2 SASH1 MINK1 CBL NHSL1 USP8 CELSR2 INF2 KIAA1217 DMD | 1.01e-07 | 421 | 162 | 13 | 36976175 | |
| Pubmed | TTC28 C2CD2L KMT2C RBM12 TRIM9 ZC3H4 NAV2 PHLPP1 GIGYF2 PRDM16 | 1.15e-07 | 225 | 162 | 10 | 12168954 | |
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 1.25e-07 | 50 | 162 | 6 | 27716508 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | CBLL1 WBP11 RAPH1 CREBBP MAP7D1 TOX4 SNW1 ZC3H4 KIAA1217 AMOTL1 PPP1R18 MAST3 | 1.45e-07 | 361 | 162 | 12 | 30344098 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 WBP11 CHERP MAP1A NUMBL DHX37 LMTK3 CBFA2T3 SRCAP SF1 ARID1B TAF3 SNW1 TCERG1 ZC3H4 YLPM1 SMARCA4 SMARCC2 DLST ZNF281 | 1.75e-07 | 1082 | 162 | 20 | 38697112 |
| Pubmed | CHERP PCLO NACA BCORL1 SMC4 ZNF524 ARID1B MAP7D1 TCERG1 SMARCC2 ZNF281 BAG6 | 3.90e-07 | 396 | 162 | 12 | 26687479 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 11581372 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 28398509 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 17150957 | ||
| Pubmed | WBP11 CHERP CARHSP1 SF1 RBM12 SNW1 TCERG1 ZC3H4 YLPM1 SMARCC2 BAG6 PML | 4.23e-07 | 399 | 162 | 12 | 35987950 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 5.95e-07 | 15 | 162 | 4 | 17255939 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 CHERP ERF BCORL1 MLXIP RREB1 SRCAP SF1 CASZ1 KMT2C MLXIPL PHC3 MAP7D1 TOX4 SNW1 TCERG1 FIZ1 YLPM1 SMARCA4 ZNF281 EP300 | 7.05e-07 | 1294 | 162 | 21 | 30804502 |
| Pubmed | GYF domain proteomics reveals interaction sites in known and novel target proteins. | 9.85e-07 | 5 | 162 | 3 | 16120600 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 21670263 | ||
| Pubmed | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. | 9.85e-07 | 5 | 162 | 3 | 10497242 | |
| Pubmed | Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. | 9.85e-07 | 5 | 162 | 3 | 11239394 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 19448667 | ||
| Pubmed | WBP11 BCORL1 SMC4 RREB1 CREBBP SF1 KMT2C ARID1B MAP7D1 RBM12 SNW1 TCERG1 ZMIZ2 SMARCA4 SMARCC2 ZNF281 BAG6 EP300 PML | 1.04e-06 | 1103 | 162 | 19 | 34189442 | |
| Pubmed | CBLL1 SETD1B UNC13D E2F4 TSC22D2 PKMYT1 KMT2C MLXIPL TAF3 SNW1 KIF2B GID4 YLPM1 PHLPP1 GIGYF2 RERE HCCS BAG6 EP300 MED13 RAB11FIP3 | 1.05e-06 | 1327 | 162 | 21 | 32694731 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.19e-06 | 40 | 162 | 5 | 34585037 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.51e-06 | 231 | 162 | 9 | 16452087 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CBLL1 WBP2 WBP11 CHERP FAM98A TSC22D2 TFG AXIN1 ARID1B SNW1 ZC3H4 AMOTL1 YLPM1 GIGYF2 DLST BAG6 MED13 | 1.61e-06 | 922 | 162 | 17 | 27609421 |
| Pubmed | PLVAP TTC28 BCORL1 FBRSL1 CBL CREBBP CASZ1 FER1L6 USP8 ARID1B SMARCC2 DLST ZNF281 EP300 | 1.94e-06 | 638 | 162 | 14 | 31182584 | |
| Pubmed | WBP11 CHERP TTC28 SCAF8 NACA RREB1 TFG C2CD2L USP8 ARID1B AMOTL1 YLPM1 SMARCA4 TANC1 POC5 | 1.94e-06 | 733 | 162 | 15 | 34672954 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 16230384 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 10887155 | ||
| Pubmed | 2.46e-06 | 128 | 162 | 7 | 23858473 | ||
| Pubmed | SEMA3F BCL9L LRFN1 CHERP SCAF8 DHX37 NACA SMC4 FAM98A CREBBP USP8 SMARCA4 DMD HCCS EP300 | 2.74e-06 | 754 | 162 | 15 | 35906200 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 20525693 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 3.42e-06 | 7 | 162 | 3 | 21079652 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 19416967 | ||
| Pubmed | Target genes of the largest human SWI/SNF complex subunit control cell growth. | 3.42e-06 | 7 | 162 | 3 | 21118156 | |
| Pubmed | Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. | 3.42e-06 | 7 | 162 | 3 | 21360626 | |
| Pubmed | Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. | 3.42e-06 | 7 | 162 | 3 | 12101239 | |
| Pubmed | Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling. | 3.42e-06 | 7 | 162 | 3 | 26138476 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 3.42e-06 | 7 | 162 | 3 | 9590696 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | SETD1B ATN1 ZNF689 BCORL1 FBRSL1 FBXL17 E2F4 RREB1 KMT2C PHC3 RERE ZNF281 | 3.96e-06 | 495 | 162 | 12 | 27705803 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DHX37 SMC4 KMT2C MAP7D1 KIF2B ZC3H4 NAV2 GIGYF2 C4A C4B BAG6 WNK4 | 4.12e-06 | 497 | 162 | 12 | 36774506 |
| Pubmed | TTC28 RAPH1 BCORL1 RREB1 PHC3 MAP7D1 TOX4 ZMIZ2 FIZ1 GIGYF2 RERE | 4.67e-06 | 418 | 162 | 11 | 34709266 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 17475621 | ||
| Pubmed | BCL9L WBP11 ATN1 PCLO NACA BCORL1 TFG CREBBP SMARCC2 BAG6 EP300 | 5.47e-06 | 425 | 162 | 11 | 24999758 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ERF CARHSP1 E2F4 TSC22D2 MLXIP ZNF524 RREB1 MLXIPL TOX4 KLF1 MZF1 ZFHX2 DMRTA1 RERE ZNF281 SMAD1 | 5.88e-06 | 908 | 162 | 16 | 19274049 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NUMBL SOBP SCAF8 SH3BP2 MINK1 FBRSL1 FBXL17 H6PD CREBBP CASZ1 KMT2C SHANK2 TMEM184A INF2 KIAA1217 ARHGAP44 ZFHX2 TANC1 RERE EP300 WNK2 | 6.33e-06 | 1489 | 162 | 21 | 28611215 |
| Pubmed | CBLL1 BCL9L ABI1 NUMBL SCAF8 MINK1 NACA SMC4 FAM98A CASZ1 C2CD2L KMT2C PHC3 MAP7D1 SHANK2 TCERG1 PPP1R18 TANC1 ZNF579 ZNF281 MED13 | 6.86e-06 | 1497 | 162 | 21 | 31527615 | |
| Pubmed | SASH1 NACA FBRSL1 KMT2C ARID1B RBM12 CASKIN2 TRIM9 ZC3H4 NAV2 MED13 WNK2 | 7.73e-06 | 529 | 162 | 12 | 14621295 | |
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 23556151 | ||
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 37805104 | ||
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 16801560 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 8.16e-06 | 9 | 162 | 3 | 20086098 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | WBP11 MAP1A NUMBL CREBBP SF1 RBM12 SNW1 TCERG1 ZNF281 SLX4 PML | 8.25e-06 | 444 | 162 | 11 | 34795231 |
| Pubmed | 8.51e-06 | 28 | 162 | 4 | 30037996 | ||
| Pubmed | 8.66e-06 | 102 | 162 | 6 | 11214970 | ||
| Pubmed | 8.66e-06 | 102 | 162 | 6 | 9734811 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.67e-06 | 220 | 162 | 8 | 35785414 | |
| Pubmed | 9.69e-06 | 104 | 162 | 6 | 10470851 | ||
| Pubmed | 9.93e-06 | 61 | 162 | 5 | 20305087 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CPEB2 BCL9L ATN1 SCAF8 TFG CREBBP KMT2C ARID1B RBM12 YLPM1 EP300 | 1.08e-05 | 457 | 162 | 11 | 32344865 |
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 1.29e-05 | 31 | 162 | 4 | 23602572 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | WBP11 LRFN1 ABI1 ERF NUMBL SMC4 E2F4 RREB1 FMNL2 CREBBP HDAC7 USP8 GID4 ARHGAP44 AMOTL1 GIGYF2 RPP25L HCCS MAST3 | 1.38e-05 | 1321 | 162 | 19 | 27173435 |
| Pubmed | 1.46e-05 | 66 | 162 | 5 | 23275444 | ||
| Pubmed | 1.51e-05 | 234 | 162 | 8 | 36243803 | ||
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 24349473 | ||
| Pubmed | Functional selectivity of recombinant mammalian SWI/SNF subunits. | 1.59e-05 | 11 | 162 | 3 | 11018012 | |
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 18003620 | ||
| Pubmed | 1.89e-05 | 34 | 162 | 4 | 30894540 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DHX37 NACA SMC4 FAM98A FMNL2 SF1 MAP7D1 SNW1 ZC3H4 SMARCA4 SMARCC2 | 1.91e-05 | 486 | 162 | 11 | 30940648 |
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 11734557 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27881875 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.16e-05 | 2 | 162 | 2 | 16565498 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15998580 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19062096 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 2.16e-05 | 2 | 162 | 2 | 34845315 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19729597 | ||
| Interaction | SP7 interactions | BCL9L WBP11 ATN1 SCAF8 FBRSL1 CBL CREBBP KMT2C ARID1B RBM12 TCERG1 ZMIZ2 YLPM1 SMARCA4 SMARCC2 RERE ZNF281 EP300 | 2.56e-11 | 304 | 156 | 18 | int:SP7 |
| Interaction | SOX7 interactions | BCORL1 RREB1 CREBBP CASZ1 KMT2C ARID1B ZMIZ2 SMARCA4 SMARCC2 PRDM16 EP300 | 3.66e-11 | 82 | 156 | 11 | int:SOX7 |
| Interaction | EGR2 interactions | BCL9L SRA1 ATN1 BCORL1 FBRSL1 RREB1 CREBBP KMT2C ARID1B ZMIZ2 RERE ZNF281 PRDM16 EP300 | 6.57e-11 | 171 | 156 | 14 | int:EGR2 |
| Interaction | GSC interactions | BCL9L ATN1 BCORL1 RREB1 CREBBP KMT2C ARID1B RERE PRDM16 EP300 SMAD1 | 7.08e-11 | 87 | 156 | 11 | int:GSC |
| Interaction | TLE3 interactions | CBLL1 BCL9L CHERP ATN1 SCAF8 BCORL1 FBRSL1 CBL CREBBP PHC3 ARID1B RBM12 ZMIZ2 SMARCA4 SMARCC2 RERE ZNF281 EP300 | 8.10e-10 | 376 | 156 | 18 | int:TLE3 |
| Interaction | CRX interactions | BCL9L ERF ATN1 NEIL2 BCORL1 FBRSL1 RREB1 TFG CREBBP KMT2C ARID1B ZMIZ2 RERE PRDM16 EP300 | 1.32e-09 | 254 | 156 | 15 | int:CRX |
| Interaction | NCK2 interactions | WBP11 ABI1 ABL2 ATN1 TTC28 RAPH1 MINK1 CBL SF1 AXIN1 NHSL1 SNW1 CASKIN2 KIAA1217 YLPM1 | 2.02e-09 | 262 | 156 | 15 | int:NCK2 |
| Interaction | PRMT2 interactions | 2.17e-09 | 91 | 156 | 10 | int:PRMT2 | |
| Interaction | AR interactions | BCL9L ABL2 CHERP ATN1 E2F4 RREB1 SRCAP CREBBP HDAC7 CASZ1 KMT2C ARID1B RBM12 SNW1 ZC3H4 KIAA1217 ZMIZ2 YLPM1 SMARCA4 SMARCC2 RERE ZNF281 BAG6 EP300 MED13 SMAD1 | 4.47e-08 | 992 | 156 | 26 | int:AR |
| Interaction | HNF4A interactions | RREB1 SRCAP CREBBP KMT2C ARID1B TAF3 SMARCA4 SMARCC2 DMD ZNF281 EP300 SLX4 PML | 2.35e-07 | 275 | 156 | 13 | int:HNF4A |
| Interaction | TBXT interactions | ATN1 FBRSL1 CREBBP KMT2C ARID1B SMARCA4 SMARCC2 ZNF281 EP300 | 2.98e-07 | 116 | 156 | 9 | int:TBXT |
| Interaction | HOXB2 interactions | 3.14e-07 | 36 | 156 | 6 | int:HOXB2 | |
| Interaction | MYOD1 interactions | CREBBP KMT2C MLXIPL ARID1B TAF3 SNW1 SMARCA4 SMARCC2 ZNF281 EP300 SMAD1 | 3.42e-07 | 194 | 156 | 11 | int:MYOD1 |
| Interaction | ACTC1 interactions | WBP11 PHACTR2 ABI1 CHERP RAPH1 SRCAP SF1 ARID1B SNW1 TCERG1 INF2 TRIM9 ZC3H4 YLPM1 SMARCA4 SMARCC2 DLST DMD SLX4 WNK2 | 4.36e-07 | 694 | 156 | 20 | int:ACTC1 |
| Interaction | TOP3B interactions | SEMA3F SPHK2 RIN3 LRFN1 SETD1B FBRSL1 MLXIP PTCH1 SRCAP HDAC7 CASZ1 C2CD2L PKMYT1 NHSL1 KMT2C SHANK2 CELSR2 INF2 ZMIZ2 ARHGAP44 NAV2 DLST TANC1 ZNF579 RPP25L PRDM16 EP300 MED13 WNK2 RAB11FIP3 | 8.49e-07 | 1470 | 156 | 30 | int:TOP3B |
| Interaction | SOX9 interactions | 8.69e-07 | 97 | 156 | 8 | int:SOX9 | |
| Interaction | GATA1 interactions | RIN3 SRA1 CREBBP ARID1B RBM12 KLF1 SMARCA4 SMARCC2 EP300 PML | 8.97e-07 | 171 | 156 | 10 | int:GATA1 |
| Interaction | SS18L1 interactions | 9.40e-07 | 98 | 156 | 8 | int:SS18L1 | |
| Interaction | PAX6 interactions | FBRSL1 RREB1 SRCAP CREBBP KMT2C ARID1B TAF3 KCNC3 SMARCA4 SMARCC2 HDAC10 ZNF281 EP300 SMAD1 | 1.03e-06 | 366 | 156 | 14 | int:PAX6 |
| Interaction | YWHAH interactions | RIN3 PHACTR2 ABI1 ABL2 SASH1 TTC28 NUMBL MINK1 FAM98A MLXIP CBL CREBBP HDAC7 NHSL1 USP8 MLXIPL MAP7D1 TCERG1 CASKIN2 KIAA1217 NAV2 GIGYF2 TANC1 WNK2 MAST3 | 1.24e-06 | 1102 | 156 | 25 | int:YWHAH |
| Interaction | CDH1 interactions | CBLL1 PHACTR2 ABI1 RAPH1 NUMBL MINK1 CBL FMNL2 CREBBP NHSL1 USP8 SHANK2 CASKIN2 KIAA1217 NAV2 PHLPP1 PPP1R18 GIGYF2 TANC1 EP300 | 2.09e-06 | 768 | 156 | 20 | int:CDH1 |
| Interaction | TRIP10 interactions | 2.11e-06 | 109 | 156 | 8 | int:TRIP10 | |
| Interaction | CTTN interactions | CBLL1 ABI1 SH3BP2 FAM98A CBL FMNL2 SF1 TOX4 SNW1 SHANK2 SMARCA4 FGD1 PHLPP1 EP300 PML | 2.30e-06 | 450 | 156 | 15 | int:CTTN |
| Interaction | SMC5 interactions | CBLL1 WBP11 CHERP BCORL1 FAM98A RREB1 HDAC7 SF1 PHC3 ARID1B TAF3 TOX4 SNW1 TCERG1 SNAP91 ZC3H4 YLPM1 SMARCA4 SMARCC2 GIGYF2 ZNF281 SLX4 PML | 2.77e-06 | 1000 | 156 | 23 | int:SMC5 |
| Interaction | P4HA3 interactions | 2.77e-06 | 113 | 156 | 8 | int:P4HA3 | |
| Interaction | CTBP1 interactions | SOBP PCLO BCORL1 FBRSL1 E2F4 RREB1 CREBBP HDAC7 SF1 PHC3 SNW1 PRDM16 BAG6 EP300 | 3.45e-06 | 406 | 156 | 14 | int:CTBP1 |
| Interaction | YAP1 interactions | WBP2 BCL9L CDIP1 ATN1 SMC4 PTCH1 SRCAP CREBBP AXIN1 KMT2C ARID1B TAF3 TOX4 SNW1 TCERG1 AMOTL1 YLPM1 SMARCA4 SMARCC2 GIGYF2 NAA30 EP300 SMAD1 PML | 3.76e-06 | 1095 | 156 | 24 | int:YAP1 |
| Interaction | ASF1A interactions | BCORL1 E2F4 RREB1 SRCAP CASZ1 ARID1B SMARCA4 SMARCC2 ZNF281 EP300 PML | 3.95e-06 | 249 | 156 | 11 | int:ASF1A |
| Interaction | DDIT3 interactions | 4.35e-06 | 120 | 156 | 8 | int:DDIT3 | |
| Interaction | NEUROD1 interactions | 4.43e-06 | 32 | 156 | 5 | int:NEUROD1 | |
| Interaction | MEN1 interactions | CHERP SETD1B ATN1 DHX37 SMC4 FAM98A SRCAP SF1 KMT2C ARID1B TOX4 SNW1 TCERG1 ZC3H4 YLPM1 SMARCA4 SMARCC2 GIGYF2 DLST C4A RERE ZNF281 SMAD1 | 4.45e-06 | 1029 | 156 | 23 | int:MEN1 |
| Interaction | ETS1 interactions | 4.62e-06 | 121 | 156 | 8 | int:ETS1 | |
| Interaction | NCOR1 interactions | E2F4 RUNX1T1 CBFA2T3 SRCAP CBL CREBBP HDAC7 SNW1 SMARCA4 SMARCC2 EP300 SLX4 PML | 5.20e-06 | 363 | 156 | 13 | int:NCOR1 |
| Interaction | H2BC21 interactions | RIN3 PCLO BCORL1 RREB1 SRCAP CBL FMNL2 CREBBP C2CD2L PKMYT1 USP8 ARID1B TOX4 ZC3H4 SMARCA4 SMARCC2 EP300 CFAP46 | 7.73e-06 | 696 | 156 | 18 | int:H2BC21 |
| Interaction | KCTD13 interactions | SHANK1 CPEB2 ABI1 VWF MAP1A NUMBL PRR36 PCLO MINK1 FAM98A FMNL2 NHSL1 MLXIPL MAP7D1 SHANK2 SNAP91 INF2 TRIM9 KIAA1217 ARHGAP44 SMARCA4 PPP1R18 SMARCC2 DLST TANC1 DMD WNK2 | 8.63e-06 | 1394 | 156 | 27 | int:KCTD13 |
| Interaction | RUNX1 interactions | WBP2 RUNX1T1 CBFA2T3 CREBBP SF1 KIF2B TCERG1 SMARCA4 SMARCC2 EP300 SMAD1 PML | 8.66e-06 | 324 | 156 | 12 | int:RUNX1 |
| Interaction | PIN1 interactions | ATN1 CARHSP1 SGK1 E2F4 CBFA2T3 TFG SF1 AXIN1 PKMYT1 ZMIZ2 BAG6 EP300 PML | 9.25e-06 | 383 | 156 | 13 | int:PIN1 |
| Interaction | KLF1 interactions | 9.30e-06 | 37 | 156 | 5 | int:KLF1 | |
| Interaction | SNRNP40 interactions | CBLL1 BCL9L WBP11 CHERP ATN1 SCAF8 NUFIP1 PHC3 ARID1B SNW1 TCERG1 ZC3H4 ZMIZ2 SMARCA4 SMARCC2 ZNF281 PML | 9.36e-06 | 637 | 156 | 17 | int:SNRNP40 |
| Interaction | YWHAZ interactions | RIN3 ABI1 ABL2 SASH1 TTC28 RAPH1 NUMBL SGK1 MINK1 MLXIP CBL TFG HDAC7 NHSL1 USP8 MLXIPL MAP7D1 AMOTL1 NAV2 GIGYF2 DLST TANC1 EP300 WNK2 MAST3 PML | 9.55e-06 | 1319 | 156 | 26 | int:YWHAZ |
| Interaction | ERG interactions | FBRSL1 CREBBP KMT2C ARID1B SMARCA4 SMARCC2 RERE ZNF281 EP300 SLX4 | 9.65e-06 | 223 | 156 | 10 | int:ERG |
| Interaction | SMAD2 interactions | E2F4 CREBBP AXIN1 KMT2C ARID1B TAF3 SNW1 SMARCA4 SMARCC2 PRDM16 EP300 SMAD1 PML | 9.78e-06 | 385 | 156 | 13 | int:SMAD2 |
| Interaction | PRPF40A interactions | WBP11 ABI1 CHERP FMNL2 SF1 TOX4 SNW1 TCERG1 YLPM1 SMARCA4 SMARCC2 BAG6 EP300 PML | 1.01e-05 | 446 | 156 | 14 | int:PRPF40A |
| Interaction | ARID1A interactions | E2F4 CREBBP USP8 ARID1B SNW1 KLF1 SMARCA4 PHLPP1 SMARCC2 EP300 SMAD1 | 1.05e-05 | 276 | 156 | 11 | int:ARID1A |
| Interaction | HDAC2 interactions | SRA1 SMC4 RUNX1T1 RREB1 CBFA2T3 CREBBP HDAC7 SF1 CASZ1 C2CD2L SNW1 INF2 SMARCA4 SMARCC2 RERE DMD HDAC10 PRDM16 EP300 PML | 1.22e-05 | 865 | 156 | 20 | int:HDAC2 |
| Interaction | NEUROG1 interactions | 1.22e-05 | 19 | 156 | 4 | int:NEUROG1 | |
| Interaction | GCM1 interactions | 1.44e-05 | 68 | 156 | 6 | int:GCM1 | |
| Interaction | HDAC1 interactions | TTC28 RAPH1 SMC4 E2F4 RUNX1T1 RREB1 CBFA2T3 CREBBP HDAC7 CASZ1 MAP7D1 TOX4 KLF1 ZMIZ2 SMARCA4 PHLPP1 SMARCC2 GIGYF2 RERE PRDM16 EP300 SMAD1 PML | 1.48e-05 | 1108 | 156 | 23 | int:HDAC1 |
| Interaction | NAA40 interactions | CHERP MAP1A RAPH1 NUMBL NACA SRCAP SF1 USP8 PHC3 TOX4 RBM12 SNW1 TCERG1 TRIM9 ZC3H4 KIAA1217 YLPM1 SMARCA4 GIGYF2 ZNF281 PML | 2.20e-05 | 978 | 156 | 21 | int:NAA40 |
| Interaction | WBP4 interactions | 2.24e-05 | 109 | 156 | 7 | int:WBP4 | |
| Interaction | GATA2 interactions | 2.54e-05 | 199 | 156 | 9 | int:GATA2 | |
| Interaction | SORBS3 interactions | 2.86e-05 | 202 | 156 | 9 | int:SORBS3 | |
| Interaction | RBM10 interactions | 2.87e-05 | 253 | 156 | 10 | int:RBM10 | |
| Interaction | UBN1 interactions | 2.94e-05 | 77 | 156 | 6 | int:UBN1 | |
| Interaction | FEV interactions | 2.98e-05 | 203 | 156 | 9 | int:FEV | |
| Interaction | YWHAG interactions | PHACTR2 ABI1 ABL2 SASH1 TTC28 RAPH1 NUMBL MINK1 FAM98A MLXIP CBL HDAC7 C2CD2L NHSL1 USP8 MLXIPL MAP7D1 TCERG1 CASKIN2 NAV2 GIGYF2 DLST TANC1 MAST3 | 3.28e-05 | 1248 | 156 | 24 | int:YWHAG |
| Interaction | HDAC3 interactions | E2F4 RUNX1T1 RREB1 CBFA2T3 CREBBP HDAC7 ARID1B SMARCA4 HDAC10 EP300 PML | 3.36e-05 | 313 | 156 | 11 | int:HDAC3 |
| Interaction | NCOR2 interactions | 4.12e-05 | 264 | 156 | 10 | int:NCOR2 | |
| Interaction | SIN3A interactions | SMC4 E2F4 RUNX1T1 CREBBP HDAC7 SF1 SNW1 KLF1 SMARCA4 SMARCC2 EP300 PML | 4.18e-05 | 380 | 156 | 12 | int:SIN3A |
| Interaction | SMAD3 interactions | E2F4 CBL CREBBP AXIN1 ARID1B SNW1 SMARCA4 SMARCC2 PRDM16 EP300 SMAD1 PML SERTAD1 | 4.65e-05 | 447 | 156 | 13 | int:SMAD3 |
| Interaction | PAX7 interactions | 5.14e-05 | 124 | 156 | 7 | int:PAX7 | |
| Interaction | YWHAQ interactions | CBLL1 RIN3 PHACTR2 ABI1 ABL2 SASH1 TTC28 NUMBL SGK1 SH3BP2 MINK1 MLXIP CBL HDAC7 NHSL1 USP8 MLXIPL MAP7D1 NAV2 DLST TANC1 WNK4 | 5.16e-05 | 1118 | 156 | 22 | int:YWHAQ |
| Interaction | KPNA2 interactions | SGK1 SMC4 PTCH1 CREBBP NUTM1 TAF3 SNW1 SMARCA4 SMARCC2 PRDM16 BAG6 EP300 SLX4 RAB11FIP3 | 5.33e-05 | 519 | 156 | 14 | int:KPNA2 |
| Interaction | ACTG1 interactions | RIN3 PHACTR2 ABI1 MAP1A SRCAP TFG FMNL2 ARID1B INF2 AMOTL1 SMARCA4 SMARCC2 SLX4 PML | 5.44e-05 | 520 | 156 | 14 | int:ACTG1 |
| Interaction | PHF20 interactions | 5.54e-05 | 53 | 156 | 5 | int:PHF20 | |
| Interaction | RUNX2 interactions | 5.69e-05 | 126 | 156 | 7 | int:RUNX2 | |
| Interaction | PPP1CC interactions | CBLL1 WBP11 RAPH1 CREBBP MAP7D1 TOX4 SNW1 INF2 ZC3H4 KIAA1217 AMOTL1 YLPM1 PPP1R18 HDAC10 EP300 SLX4 MAST3 | 6.03e-05 | 738 | 156 | 17 | int:PPP1CC |
| Interaction | ABI1 interactions | 6.18e-05 | 223 | 156 | 9 | int:ABI1 | |
| Interaction | TLX1 interactions | 6.71e-05 | 175 | 156 | 8 | int:TLX1 | |
| Interaction | RBM15 interactions | 6.71e-05 | 175 | 156 | 8 | int:RBM15 | |
| Interaction | PAX9 interactions | 6.93e-05 | 130 | 156 | 7 | int:PAX9 | |
| Interaction | H3C1 interactions | SPHK2 WBP11 CHERP SETD1B DHX37 NACA SRCAP CREBBP KMT2C MAP7D1 TAF3 SNW1 ZC3H4 NAV2 SMARCA4 SMARCC2 ZNF281 PRDM16 EP300 | 7.11e-05 | 901 | 156 | 19 | int:H3C1 |
| Interaction | KLF3 interactions | 7.33e-05 | 228 | 156 | 9 | int:KLF3 | |
| Interaction | EP300 interactions | WBP11 NEIL2 NACA SMC4 E2F4 SRCAP CBL CREBBP HDAC7 SF1 NUTM1 MLXIPL SNW1 KLF1 ZC3H4 YLPM1 SMARCA4 SMARCC2 C4A RERE BAG6 EP300 SMAD1 PML SERTAD1 | 7.48e-05 | 1401 | 156 | 25 | int:EP300 |
| Interaction | FXR1 interactions | SHANK1 RIN3 ABI1 VWF ATN1 E2F4 LMTK3 AXIN1 SNW1 SMARCA4 SMARCC2 GIGYF2 PRDM16 EP300 PML SERTAD1 | 7.71e-05 | 679 | 156 | 16 | int:FXR1 |
| Interaction | MAPRE3 interactions | 7.84e-05 | 230 | 156 | 9 | int:MAPRE3 | |
| Interaction | ACTB interactions | RIN3 PHACTR2 ABI1 SRA1 MAP1A RAPH1 NUMBL SRCAP CBL CREBBP NHSL1 ARID1B SNW1 INF2 TRIM9 SMARCA4 PPP1R18 SMARCC2 TANC1 EP300 SLX4 | 9.56e-05 | 1083 | 156 | 21 | int:ACTB |
| Interaction | PIAS3 interactions | 9.63e-05 | 95 | 156 | 6 | int:PIAS3 | |
| Interaction | VASP interactions | 1.01e-04 | 294 | 156 | 10 | int:VASP | |
| Interaction | TERF2IP interactions | WBP11 E2F4 RREB1 SRCAP CREBBP PHC3 SNW1 TCERG1 ZC3H4 SMARCA4 SMARCC2 ZNF281 SLX4 PML | 1.03e-04 | 552 | 156 | 14 | int:TERF2IP |
| Interaction | ATN1 interactions | 1.07e-04 | 187 | 156 | 8 | int:ATN1 | |
| Interaction | WWTR1 interactions | WBP2 TTC28 RAPH1 SRCAP CBL CREBBP ARID1B TOX4 TCERG1 AMOTL1 SMARCA4 EP300 | 1.13e-04 | 422 | 156 | 12 | int:WWTR1 |
| Interaction | HDLBP interactions | WBP11 ABL2 NACA FMNL2 SF1 MAP7D1 TAF3 TOX4 SNW1 TCERG1 YLPM1 SMARCA4 PHLPP1 SMARCC2 RPP25L SLX4 MAST3 PML | 1.14e-04 | 855 | 156 | 18 | int:HDLBP |
| Interaction | HIPK2 interactions | 1.14e-04 | 98 | 156 | 6 | int:HIPK2 | |
| Interaction | EYA4 interactions | 1.19e-04 | 243 | 156 | 9 | int:EYA4 | |
| Interaction | SMARCB1 interactions | SMC4 E2F4 SRCAP CREBBP KMT2C ARID1B KLF1 SMARCA4 SMARCC2 DLST EP300 | 1.29e-04 | 364 | 156 | 11 | int:SMARCB1 |
| Interaction | SHANK3 interactions | SHANK1 BCL9L WBP11 ABI1 ATN1 MAP1A NACA LMTK3 USP8 SHANK2 SNAP91 TRIM9 ARHGAP44 | 1.32e-04 | 496 | 156 | 13 | int:SHANK3 |
| Interaction | TSC1 interactions | SHANK1 RIN3 ABI1 ATN1 MINK1 AXIN1 CELSR2 PHLPP1 PPP1R18 WNK2 SERTAD1 | 1.36e-04 | 366 | 156 | 11 | int:TSC1 |
| Interaction | MAGI1 interactions | 1.50e-04 | 147 | 156 | 7 | int:MAGI1 | |
| Interaction | E2F5 interactions | 1.68e-04 | 36 | 156 | 4 | int:E2F5 | |
| Interaction | PFN1 interactions | ABI1 MAP1A RAPH1 NUMBL PCLO CBL FMNL2 NHSL1 INF2 KIAA1217 PHLPP1 DLST TANC1 | 1.70e-04 | 509 | 156 | 13 | int:PFN1 |
| Interaction | ARHGAP12 interactions | 1.83e-04 | 68 | 156 | 5 | int:ARHGAP12 | |
| Interaction | STAT3 interactions | ABL2 SH3BP2 PTCH1 CBL CREBBP ARID1B SMARCA4 PHLPP1 ZNF281 EP300 SMAD1 PML | 1.89e-04 | 446 | 156 | 12 | int:STAT3 |
| Interaction | ETV4 interactions | 1.97e-04 | 69 | 156 | 5 | int:ETV4 | |
| Interaction | SF3B2 interactions | RIN3 CHERP SMC4 SF1 TOX4 SNW1 TCERG1 PHLPP1 GIGYF2 DMD EP300 SLX4 SMAD1 | 1.98e-04 | 517 | 156 | 13 | int:SF3B2 |
| Interaction | SMARCC1 interactions | SMC4 E2F4 SRCAP CREBBP ARID1B KLF1 YLPM1 SMARCA4 SMARCC2 EP300 SLX4 | 2.06e-04 | 384 | 156 | 11 | int:SMARCC1 |
| Interaction | H3C14 interactions | 2.16e-04 | 156 | 156 | 7 | int:H3C14 | |
| Interaction | PAX8 interactions | 2.27e-04 | 111 | 156 | 6 | int:PAX8 | |
| Interaction | PCBP1 interactions | RIN3 CARHSP1 NACA SF1 RBM12 SNW1 TCERG1 KLF1 GIGYF2 PCBP4 ZNF281 EP300 SLX4 MAST3 PML | 2.30e-04 | 671 | 156 | 15 | int:PCBP1 |
| Interaction | KHDC1 interactions | 2.37e-04 | 16 | 156 | 3 | int:KHDC1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 SPHK2 LRFN1 ERF NUMBL OSCAR ZNF524 LMTK3 GFY KCNC3 MZF1 ZC3H4 FIZ1 C19orf84 ZNF579 SERTAD1 | 5.59e-06 | 1192 | 162 | 16 | chr19q13 |
| Cytoband | 16p13.3 | 2.43e-04 | 244 | 162 | 6 | 16p13.3 | |
| Cytoband | 9q22.3 | 7.98e-04 | 12 | 162 | 2 | 9q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 8.39e-04 | 426 | 162 | 7 | chr16p13 | |
| Cytoband | 19q13.42 | 1.04e-03 | 125 | 162 | 4 | 19q13.42 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.42e-04 | 18 | 104 | 3 | 91 | |
| GeneFamily | Sterile alpha motif domain containing | 1.53e-04 | 88 | 104 | 5 | 760 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.25e-04 | 181 | 104 | 6 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.72e-04 | 34 | 104 | 3 | 487 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.15e-03 | 9 | 104 | 2 | 1234 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF689 ZNF524 RREB1 CASZ1 KLF1 MZF1 FIZ1 ZFHX2 ZNF579 ZNF281 PRDM16 | 2.80e-03 | 718 | 104 | 11 | 28 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SPHK2 ATN1 SH3BP2 MINK1 FBRSL1 UNC13D ZNF524 SRCAP HDAC7 SF1 ZMIZ2 SMARCA4 HDAC10 | 1.61e-07 | 338 | 159 | 13 | M17094 |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | ABI1 SCAF8 FBXL17 ZNF524 TAF3 PHLPP1 HDAC10 PRDM16 FCHSD1 SERTAD1 | 4.25e-07 | 200 | 159 | 10 | M9336 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | SPHK2 SETD1B SGK1 E2F4 LMTK3 CREBBP SF1 CASZ1 AXIN1 MAP7D1 MZF1 ZMIZ2 SMARCA4 PPP1R18 SMARCC2 EP300 | 1.70e-06 | 634 | 159 | 16 | M40866 |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 3.88e-06 | 200 | 159 | 9 | M8007 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | ABI1 ABL2 NACA RUNX1T1 CBFA2T3 CBL TFG CREBBP PRDM16 EP300 PML | 4.80e-06 | 323 | 159 | 11 | M9150 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 1.74e-05 | 184 | 159 | 8 | M19988 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN | 2.84e-05 | 197 | 159 | 8 | M5879 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 3.05e-05 | 199 | 159 | 8 | M9031 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP | 3.17e-05 | 200 | 159 | 8 | M5800 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP | 3.17e-05 | 200 | 159 | 8 | M8469 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.04e-05 | 157 | 159 | 7 | M7733 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CDIP1 PHACTR2 MAP1A RAPH1 SOBP PCLO FBXL17 RUNX1T1 PTCH1 KMT2C MLXIPL SNAP91 TRIM9 NAV2 GIGYF2 CYP2U1 RERE | 6.54e-05 | 946 | 159 | 17 | M39169 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | WBP2 BCL9L WBP11 PHACTR2 PLVAP ATN1 MAP1A NUMBL NACA E2F4 HDAC7 MAP7D1 C4A C4B | 7.83e-05 | 685 | 159 | 14 | MM3782 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | MAP1A PRR36 PCLO SMC4 FMNL2 MLXIPL CELSR2 KLF1 ZFHX2 PHLPP1 ZNF579 DMD PRDM16 WNK2 | 1.85e-05 | 496 | 156 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TTC28 FBXL17 NHSL1 ARID1B SHANK2 ARHGAP44 NAV2 TANC1 RERE DMD | 3.14e-09 | 198 | 162 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.92e-08 | 193 | 162 | 9 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.02e-07 | 199 | 162 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.29e-07 | 200 | 162 | 8 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 187 | 162 | 7 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 187 | 162 | 7 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.67e-06 | 187 | 162 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.87e-06 | 188 | 162 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-06 | 189 | 162 | 7 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.29e-06 | 190 | 162 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 6.51e-06 | 191 | 162 | 7 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-06 | 195 | 162 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 196 | 162 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 197 | 162 | 7 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 197 | 162 | 7 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.97e-06 | 197 | 162 | 7 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 198 | 162 | 7 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.36e-05 | 142 | 162 | 6 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-05 | 154 | 162 | 6 | b944be7fc30d8897d52689f2b2622ff7ede8a6a1 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 3.17e-05 | 165 | 162 | 6 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 3.17e-05 | 165 | 162 | 6 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.74e-05 | 170 | 162 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 171 | 162 | 6 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-05 | 173 | 162 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.54e-05 | 176 | 162 | 6 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 179 | 162 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-05 | 179 | 162 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-05 | 184 | 162 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.99e-05 | 185 | 162 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.99e-05 | 185 | 162 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.99e-05 | 185 | 162 | 6 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.17e-05 | 186 | 162 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.17e-05 | 186 | 162 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 6.36e-05 | 187 | 162 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.55e-05 | 188 | 162 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 188 | 162 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.55e-05 | 188 | 162 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 6.55e-05 | 188 | 162 | 6 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | facs-Lung|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 188 | 162 | 6 | f7292fc8e914f222828dcdb0a017d716207a97f6 | |
| ToppCell | facs-Lung|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | e2b6e14579ec649a2bc106d9c99bb78ceb16ede3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 189 | 162 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 189 | 162 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.74e-05 | 189 | 162 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 6.94e-05 | 190 | 162 | 6 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.94e-05 | 190 | 162 | 6 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-05 | 190 | 162 | 6 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.94e-05 | 190 | 162 | 6 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.94e-05 | 190 | 162 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.15e-05 | 191 | 162 | 6 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 7.15e-05 | 191 | 162 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 191 | 162 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 7.15e-05 | 191 | 162 | 6 | 44a797b39254cbfa5c2bad8155436adfd3019bb0 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 191 | 162 | 6 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.15e-05 | 191 | 162 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 7.15e-05 | 191 | 162 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 191 | 162 | 6 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | facs-Kidney-nan-18m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 777e386a17bba9ec450bb9d64d8a9ab98d9a63ff | |
| ToppCell | facs-Kidney-nan-18m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 60a2409546525a40a5658e0f9d6a50c37f28bb96 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.35e-05 | 192 | 162 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 7.35e-05 | 192 | 162 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Kidney-nan-18m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 0f9db6091b373334b9beabe0e5782bf2bc54690b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.35e-05 | 192 | 162 | 6 | 517bc24b9ad5e2b5a3609ca55d7327c4700db9db | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-05 | 192 | 162 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 193 | 162 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-05 | 193 | 162 | 6 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-05 | 193 | 162 | 6 | 0f19b6384659a5bcc11b45dc2df8454b96ddf4cd | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 193 | 162 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-05 | 193 | 162 | 6 | a586727dc23b0777770f54fc8d4fe5f30b68439f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 193 | 162 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 193 | 162 | 6 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 194 | 162 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-05 | 194 | 162 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.79e-05 | 194 | 162 | 6 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 194 | 162 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.79e-05 | 194 | 162 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.79e-05 | 194 | 162 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | facs-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.79e-05 | 194 | 162 | 6 | 3b5ba12375102598468cb09e66af9241b66c3cf9 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.79e-05 | 194 | 162 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 7.79e-05 | 194 | 162 | 6 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-05 | 194 | 162 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.01e-05 | 195 | 162 | 6 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | 5b84fd5be31386eb1d6048bbf28626032361842e | |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | SEMA3F PLVAP ATN1 PRR36 SH3BP2 MINK1 H6PD GABBR2 HDAC7 PML MYBPC3 | 1.28e-07 | 197 | 157 | 11 | 4121_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | ABL2 ATN1 SH3BP2 MINK1 SMC4 SRCAP C2CD2L CASKIN2 ARHGAP44 FGD1 ZFHX2 | 1.35e-07 | 198 | 157 | 11 | 5583_DN |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A | PLVAP ABL2 SH3BP2 TSC22D2 PTCH1 SRCAP GABBR2 SHANK2 MZF1 FGD1 | 7.24e-07 | 187 | 157 | 10 | 5678_UP |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | WBP2 SPHK2 ATN1 SH3BP2 BCORL1 C2CD2L CASKIN2 SMARCA4 RERE MAST3 | 9.66e-07 | 193 | 157 | 10 | 3262_UP |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | SPHK2 SH3BP2 MINK1 POM121L2 MLXIP ASIC3 SRCAP GABBR2 FGD1 SMARCC2 | 1.06e-06 | 195 | 157 | 10 | 2833_UP |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | 1.16e-06 | 197 | 157 | 10 | 284_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 1.16e-06 | 197 | 157 | 10 | 4295_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | SETD1B MINK1 POM121L2 MAGEC3 GABBR2 KLF1 CASKIN2 ZMIZ2 SMARCC2 PML | 1.16e-06 | 197 | 157 | 10 | 3209_UP |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | SEMA3F SETD1B SH3BP2 BCORL1 H6PD GABBR2 SHANK2 ZMIZ2 MAST3 PML | 1.22e-06 | 198 | 157 | 10 | 3237_UP |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 1.22e-06 | 198 | 157 | 10 | 7549_UP | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | SEMA3F TTC28 E2F4 ASIC3 CBL CELSR2 CASKIN2 PCBP4 EP300 RAB11FIP3 | 1.28e-06 | 199 | 157 | 10 | 1811_UP |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A | SEMA3F ATN1 MAP1A POM121L2 E2F4 TSC22D2 CBL CASKIN2 SMAD1 PML | 1.33e-06 | 200 | 157 | 10 | 7329_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.87e-06 | 170 | 157 | 9 | 3746_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.64e-06 | 175 | 157 | 9 | 1058_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.79e-06 | 181 | 157 | 9 | 6951_DN | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A | 7.41e-06 | 191 | 157 | 9 | 4247_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.76e-06 | 195 | 157 | 9 | 7435_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 8.76e-06 | 195 | 157 | 9 | 1630_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 9.13e-06 | 196 | 157 | 9 | 4535_UP | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; PC3; HT_HG-U133A | 9.13e-06 | 196 | 157 | 9 | 3985_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.51e-06 | 197 | 157 | 9 | 6241_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 9.51e-06 | 197 | 157 | 9 | 4730_UP | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 9.90e-06 | 198 | 157 | 9 | 2847_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.90e-06 | 198 | 157 | 9 | 2242_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 1.03e-05 | 199 | 157 | 9 | 3381_DN | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 1.03e-05 | 199 | 157 | 9 | 7071_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HG-U133A | 1.03e-05 | 199 | 157 | 9 | 1888_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.03e-05 | 199 | 157 | 9 | 4297_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.03e-05 | 199 | 157 | 9 | 4843_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.03e-05 | 199 | 157 | 9 | 2287_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.65e-05 | 172 | 157 | 8 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.88e-05 | 174 | 157 | 8 | 3993_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.88e-05 | 174 | 157 | 8 | 1659_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.00e-05 | 175 | 157 | 8 | 5935_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.66e-05 | 180 | 157 | 8 | 6886_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 4.99e-05 | 188 | 157 | 8 | 345_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA | 5.18e-05 | 189 | 157 | 8 | 989_UP | |
| Drug | Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.58e-05 | 191 | 157 | 8 | 5344_UP | |
| Drug | ethylene | 5.92e-05 | 142 | 157 | 7 | CID000006325 | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 6.00e-05 | 193 | 157 | 8 | 3124_DN | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.00e-05 | 193 | 157 | 8 | 2078_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 6.00e-05 | 193 | 157 | 8 | 7057_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; HL60; HT_HG-U133A | 6.00e-05 | 193 | 157 | 8 | 2567_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 6.00e-05 | 193 | 157 | 8 | 6345_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 193 | 157 | 8 | 5268_UP | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 2284_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 3861_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 4174_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A | 6.22e-05 | 194 | 157 | 8 | 1422_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 2793_DN | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 6.22e-05 | 194 | 157 | 8 | 263_UP | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 6.45e-05 | 195 | 157 | 8 | 834_UP | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 3278_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 2087_UP | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 4105_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 3941_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 4180_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 7106_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 4324_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 3719_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 6.45e-05 | 195 | 157 | 8 | 166_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 5063_DN | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 3263_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 5604_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 2991_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 2315_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 1666_UP | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7391_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 2288_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 4494_DN | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7335_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 4204_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 6335_DN | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 7484_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 5483_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 3004_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 4631_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 5597_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 6811_UP | |
| Drug | Trichlormethiazide [133-67-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 3337_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 7230_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 3877_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 5592_DN | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 7013_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 4762_DN | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 6592_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 4498_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 3632_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 4569_DN | |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 5943_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 3764_DN | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 5492_UP | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 4142_UP | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 2279_DN | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; HL60; HG-U133A | 7.18e-05 | 198 | 157 | 8 | 1594_UP | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 4020_DN | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; HL60; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 3109_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 7.18e-05 | 198 | 157 | 8 | 205_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 6742_DN | |
| Drug | Pipemidic acid [51940-44-4]; Up 200; 13.2uM; HL60; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 3093_UP | |
| Disease | mean platelet volume | SEMA3F RIN3 VWF SETD1B TTC28 NACA BCORL1 FBRSL1 UNC13D TSC22D2 CBFA2T3 SRCAP HDAC7 MLXIPL TOX4 ZMIZ2 PRDM16 MYBPC3 RAB11FIP3 | 2.72e-06 | 1020 | 159 | 19 | EFO_0004584 |
| Disease | Charcot-Marie-Tooth disease dominant intermediate E (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:0110205 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.89e-05 | 2 | 159 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.89e-05 | 2 | 159 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 2.89e-05 | 2 | 159 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.89e-05 | 2 | 159 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.89e-05 | 2 | 159 | 2 | C4551859 | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.89e-05 | 2 | 159 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.89e-05 | 2 | 159 | 2 | C0035934 | |
| Disease | cardiovascular disease | CPEB2 FBRSL1 UNC13D TSC22D2 CASZ1 AXIN1 CELSR2 SMARCA4 RERE PRDM16 MYBPC3 | 4.04e-05 | 457 | 159 | 11 | EFO_0000319 |
| Disease | Coffin-Siris syndrome | 4.22e-05 | 13 | 159 | 3 | C0265338 | |
| Disease | glucose measurement | FBRSL1 RREB1 AXIN1 SNAP91 ZC3H4 ZMIZ2 DMRTA1 PRDM16 MYBPC3 RAB11FIP3 | 4.35e-05 | 380 | 159 | 10 | EFO_0004468 |
| Disease | Leukemia, Myelocytic, Acute | 4.45e-05 | 173 | 159 | 7 | C0023467 | |
| Disease | Schizoaffective disorder-bipolar type | 8.17e-05 | 16 | 159 | 3 | EFO_0009965 | |
| Disease | serine/threonine-protein kinase PAK 6 measurement | 8.63e-05 | 3 | 159 | 2 | EFO_0020729 | |
| Disease | mean reticulocyte volume | SPHK2 RAPH1 FBRSL1 E2F4 MLXIP CBFA2T3 HDAC7 SF1 USP8 MLXIPL KLF1 KIAA1217 PRDM16 BAG6 | 1.15e-04 | 799 | 159 | 14 | EFO_0010701 |
| Disease | cortical surface area measurement | RIN3 ABI1 RAPH1 FBXL17 TSC22D2 RUNX1T1 RREB1 PTCH1 FMNL2 AXIN1 SMAD5-AS1 PKMYT1 NHSL1 ARID1B MTMR11 NAV2 DMRTA1 RERE WNK2 | 1.22e-04 | 1345 | 159 | 19 | EFO_0010736 |
| Disease | Neurodevelopmental Disorders | 1.51e-04 | 93 | 159 | 5 | C1535926 | |
| Disease | age at diagnosis, type 2 diabetes mellitus | 1.72e-04 | 4 | 159 | 2 | EFO_0004918, MONDO_0005148 | |
| Disease | triglyceride measurement, coronary artery disease | 1.72e-04 | 4 | 159 | 2 | EFO_0001645, EFO_0004530 | |
| Disease | reticulocyte measurement | SEMA3F SPHK2 VWF PLVAP TSC22D2 RREB1 CBFA2T3 CBL NUFIP1 MLXIPL KLF1 ZC3H4 DMRTA1 ZDHHC19 FHDC1 PRDM16 | 1.91e-04 | 1053 | 159 | 16 | EFO_0010700 |
| Disease | Small cell carcinoma of lung | 2.08e-04 | 54 | 159 | 4 | C0149925 | |
| Disease | Adenoid Cystic Carcinoma | 2.13e-04 | 100 | 159 | 5 | C0010606 | |
| Disease | neurotic disorder | 2.23e-04 | 101 | 159 | 5 | EFO_0004257 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.40e-04 | 56 | 159 | 4 | EFO_0022235 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 2.41e-04 | 227 | 159 | 7 | EFO_0004346, EFO_0010736 | |
| Disease | Chromosome 1p36 Deletion Syndrome | 2.85e-04 | 5 | 159 | 2 | C1842870 | |
| Disease | stem Cell Growth Factor-beta measurement | 2.85e-04 | 5 | 159 | 2 | EFO_0802090 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.85e-04 | 5 | 159 | 2 | C3281201 | |
| Disease | mean corpuscular hemoglobin concentration | SETD1B ATN1 TTC28 FBRSL1 FBXL17 RREB1 HDAC7 AXIN1 MLXIPL KLF1 KIAA1217 DMRTA1 ZDHHC19 PRDM16 MED13 SMAD1 | 3.27e-04 | 1105 | 159 | 16 | EFO_0004528 |
| Disease | free cholesterol in very large HDL measurement | 3.55e-04 | 62 | 159 | 4 | EFO_0022273 | |
| Disease | Sezary Syndrome | 4.08e-04 | 27 | 159 | 3 | C0036920 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 4.27e-04 | 6 | 159 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.88e-04 | 335 | 159 | 8 | EFO_0009931 | |
| Disease | reticulocyte count | SEMA3F SPHK2 VWF PLVAP TSC22D2 RREB1 CBL NUFIP1 MLXIPL KLF1 ZC3H4 DMRTA1 C4B ZDHHC19 FHDC1 | 5.52e-04 | 1045 | 159 | 15 | EFO_0007986 |
| Disease | stem cell growth factor-alpha measurement | 5.95e-04 | 7 | 159 | 2 | EFO_0020754 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.81e-04 | 195 | 159 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | metabolic syndrome | 7.78e-04 | 200 | 159 | 6 | EFO_0000195 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 7.91e-04 | 8 | 159 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | brain measurement, neuroimaging measurement | RIN3 TSC22D2 RUNX1T1 RREB1 PTCH1 NHSL1 NAV2 DMRTA1 PRDM16 WNK2 | 8.37e-04 | 550 | 159 | 10 | EFO_0004346, EFO_0004464 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 8.38e-04 | 364 | 159 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | serum alanine aminotransferase measurement | CARHSP1 PCLO BCORL1 FBXL17 CDCP2 TSC22D2 MLXIP PTCH1 MLXIPL CELSR2 ZC3H4 WNK2 MAST3 | 8.92e-04 | 869 | 159 | 13 | EFO_0004735 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.60e-04 | 139 | 159 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | SPHK2 SETD1B TTC28 FBRSL1 UNC13D CBFA2T3 AXIN1 MLXIPL KLF1 ZC3H4 KIAA1217 YLPM1 DMRTA1 ZDHHC19 EP300 SMAD1 MAST3 | 9.97e-04 | 1347 | 159 | 17 | EFO_0005192 |
| Disease | lymphocyte percentage of leukocytes | SPHK2 RIN3 TTC28 MINK1 CBFA2T3 HDAC7 KLF1 DMRTA1 RERE PRDM16 SERTAD1 | 1.00e-03 | 665 | 159 | 11 | EFO_0007993 |
| Disease | Osteitis Deformans | 1.01e-03 | 9 | 159 | 2 | C0029401 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.01e-03 | 9 | 159 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | PCLO FBXL17 TSC22D2 PTCH1 KIAA1217 ZMIZ2 YLPM1 NAV2 RERE MAST3 | 1.04e-03 | 566 | 159 | 10 | EFO_0007660, EFO_0008354 |
| Disease | cortical thickness | RIN3 TSC22D2 RUNX1T1 RREB1 PTCH1 FMNL2 SMAD5-AS1 NHSL1 ARID1B SNAP91 YLPM1 NAV2 DMRTA1 RERE WNK2 | 1.04e-03 | 1113 | 159 | 15 | EFO_0004840 |
| Disease | alanine measurement | 1.22e-03 | 86 | 159 | 4 | EFO_0009765 | |
| Disease | photoreceptor cell layer thickness measurement | 1.27e-03 | 148 | 159 | 5 | EFO_0803370 | |
| Disease | white matter microstructure measurement | 1.30e-03 | 390 | 159 | 8 | EFO_0005674 | |
| Disease | IGF-1 measurement | 1.38e-03 | 488 | 159 | 9 | EFO_0004627 | |
| Disease | Carcinoma, Transitional Cell | 1.41e-03 | 41 | 159 | 3 | C0007138 | |
| Disease | trypsin-3 measurement | 1.54e-03 | 11 | 159 | 2 | EFO_0020791 | |
| Disease | meningitis | 1.54e-03 | 11 | 159 | 2 | MONDO_0021108 | |
| Disease | Paroxysmal atrial fibrillation | 1.60e-03 | 156 | 159 | 5 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 1.60e-03 | 156 | 159 | 5 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 1.60e-03 | 156 | 159 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.60e-03 | 156 | 159 | 5 | C2585653 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.62e-03 | 43 | 159 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | triglycerides in large LDL measurement | 1.62e-03 | 43 | 159 | 3 | EFO_0022319 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.62e-03 | 43 | 159 | 3 | EFO_0022290 | |
| Disease | cholesteryl ester 20:4 measurement | 1.73e-03 | 44 | 159 | 3 | EFO_0010348 | |
| Disease | Familial dilated cardiomyopathy | 1.73e-03 | 44 | 159 | 3 | C0340427 | |
| Disease | myeloid white cell count | SPHK2 RIN3 SETD1B ERF TTC28 RREB1 FMNL2 HDAC7 USP8 MLXIPL DMRTA1 RERE SERTAD1 | 1.75e-03 | 937 | 159 | 13 | EFO_0007988 |
| Disease | Atrial Fibrillation | 1.79e-03 | 160 | 159 | 5 | C0004238 | |
| Disease | neutrophil percentage of leukocytes | SPHK2 RIN3 ZNF689 MINK1 HDAC7 MLXIPL KLF1 DMRTA1 RERE SERTAD1 | 1.81e-03 | 610 | 159 | 10 | EFO_0007990 |
| Disease | rac GTPase-activating protein 1 measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0801985 | |
| Disease | forced expiratory volume, traffic air pollution measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0004314, EFO_0007908 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.85e-03 | 45 | 159 | 3 | EFO_0022236 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.97e-03 | 46 | 159 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | neuroimaging measurement | FAM98A TSC22D2 RUNX1T1 RREB1 PTCH1 NHSL1 MLXIPL SNAP91 NAV2 DLST DMRTA1 RERE PRDM16 WNK2 | 2.00e-03 | 1069 | 159 | 14 | EFO_0004346 |
| Disease | free cholesterol in medium VLDL measurement | 2.09e-03 | 47 | 159 | 3 | EFO_0022269 | |
| Disease | osteitis deformans | 2.16e-03 | 13 | 159 | 2 | EFO_0004261 | |
| Disease | total lipids in lipoprotein particles measurement | 2.22e-03 | 48 | 159 | 3 | EFO_0022309 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 2.36e-03 | 49 | 159 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.36e-03 | 49 | 159 | 3 | EFO_0022256 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.36e-03 | 49 | 159 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | cup-to-disc ratio measurement | 2.39e-03 | 430 | 159 | 8 | EFO_0006939 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.50e-03 | 50 | 159 | 3 | EFO_0022334 | |
| Disease | asthma, body mass index | 2.52e-03 | 14 | 159 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | Left ventricular noncompaction | 2.52e-03 | 14 | 159 | 2 | C1960469 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.52e-03 | 14 | 159 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.65e-03 | 51 | 159 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.65e-03 | 51 | 159 | 3 | EFO_0022331 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.65e-03 | 51 | 159 | 3 | EFO_0022242 | |
| Disease | phospholipids in medium VLDL measurement | 2.80e-03 | 52 | 159 | 3 | EFO_0022154 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.95e-03 | 53 | 159 | 3 | EFO_0022340 | |
| Disease | cholesterol in small VLDL measurement | 2.95e-03 | 53 | 159 | 3 | EFO_0022228 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.11e-03 | 111 | 159 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | IGFBP-3 measurement | 3.11e-03 | 54 | 159 | 3 | EFO_0004626 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 3.11e-03 | 54 | 159 | 3 | EFO_0022244 | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.28e-03 | 55 | 159 | 3 | C0079744 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.28e-03 | 55 | 159 | 3 | EFO_0022234 | |
| Disease | response to antineoplastic agent, response to antimicrotubule agent | 3.29e-03 | 16 | 159 | 2 | EFO_0005260, GO_0097327 | |
| Disease | nervousness | 3.29e-03 | 16 | 159 | 2 | NCIT_C74532 | |
| Disease | ankle brachial index | 3.29e-03 | 16 | 159 | 2 | EFO_0003912 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPMAPETPPVPSSAS | 351 | P50548 | |
| ATTIPAPVPTPPAMP | 856 | Q09472 | |
| APVPTPPAMPPGPQS | 861 | Q09472 | |
| PPAMPPGPQSQALHP | 866 | Q09472 | |
| PTSQPQPTPPNSMPP | 1871 | Q09472 | |
| HAAMFAAPPTLPPPP | 376 | Q9HCM7 | |
| MSSEPPPPYPGGPTA | 1 | Q9H305 | |
| PTPGRSSPAVMQPPP | 26 | Q9H305 | |
| VSPTPAPRNPSDPMP | 1241 | P0C0L5 | |
| MPPPQVPLPTSSISP | 1041 | P42684 | |
| PAQPPPTPQPSMADL | 591 | P46379 | |
| PPPAPEQQTMPPPGS | 666 | P46379 | |
| PMAPSSPPVPPVTTA | 1081 | Q86V15 | |
| SPSSIPPVCPAPPMN | 396 | Q5VXM1 | |
| PTSRMFQAPPGAPPP | 201 | P54259 | |
| PPPVPTPRKPAFSDM | 206 | P78314 | |
| PVLAPMPASTPPAAP | 336 | Q5H9F3 | |
| MPASTPPAAPAPPSV | 341 | Q5H9F3 | |
| APPSVPMPTPTPSSG | 351 | Q5H9F3 | |
| PAPIFTPAPTPMPAA | 386 | Q5H9F3 | |
| HTTPPGMTPPQPAAP | 871 | Q92793 | |
| AMKPPGDVPEPQPTP | 1251 | Q8IYW2 | |
| SQNSISIAPPPPPMP | 356 | Q8IZP0 | |
| LPMALGAPQPPPAAS | 411 | Q8IY63 | |
| TPPMTLPSPPTLPAQ | 146 | I3L1E1 | |
| PASIPGSQMPPQPPG | 826 | Q8NFD5 | |
| PAGQPAPVSMVPPSP | 731 | O60641 | |
| PSNLMPPPNQTPAPD | 81 | P53701 | |
| MRSPATGVPLPTPPP | 1 | Q9HCU4 | |
| LSPLPSPPEMMPTSP | 3536 | P11532 | |
| APMPAEPAPPGPASP | 741 | Q9HBB8 | |
| APVPTMPPALQPFPA | 451 | Q9Y6R0 | |
| PSTASPMNTVPPPPI | 176 | Q9NTZ6 | |
| PPPPTPGSAMAQLKP | 716 | Q70E73 | |
| ASQFPPPPTPPAMES | 866 | Q70E73 | |
| MASAPPASPPGSEPP | 1 | O75154 | |
| APGFMIGQTPPPAPP | 21 | Q9C0D6 | |
| KPMPFLALPPASPGP | 361 | P57723 | |
| LDPSAPPMPLPVTSP | 401 | Q8NA72 | |
| PQPPLIPGATPPTMS | 3286 | Q8NEZ4 | |
| RPEPGPSMEPSLTPP | 2046 | P78559 | |
| AAGMPPLPQSPPEIP | 381 | Q8TD91 | |
| EMGPPGSSPTPEPPQ | 61 | Q969S2 | |
| LTPPTMPPPPTTQGA | 51 | Q06455 | |
| PRPQPSFMVPGPPSS | 546 | A4FU01 | |
| PLMAPPPAAPPPLTE | 391 | Q9P244 | |
| PMAPPASAPPEFLDP | 721 | Q96Q04 | |
| MAPDPQLLPPPSSPS | 266 | Q5VYM1 | |
| SSEPPPAPPLDPKFM | 1021 | Q5SYE7 | |
| PPAPSGPKASPMPVP | 1126 | Q9Y6V0 | |
| SRPMGPVPNPQPIDP | 401 | Q9BX97 | |
| RPPAPPGFMPSPTFD | 131 | Q9UHC3 | |
| KSMVPPPPVAPAPSP | 321 | O75167 | |
| TPPSMPPPPPAASQG | 76 | O75081 | |
| PIPIASPPQMSTSPP | 496 | Q8NDX5 | |
| SPPQMSTSPPAQIPP | 501 | Q8NDX5 | |
| TPLAPSPAMQPPVPP | 1051 | Q8WXE0 | |
| TAPPPPPLPGLGAMA | 456 | Q27J81 | |
| PPQPIMPSVFSPDNP | 46 | Q86Y26 | |
| PASSAPGMQAPGPPP | 226 | Q8IYS5 | |
| LPLPPALAPGDPAMP | 71 | Q8IVV7 | |
| QAPPPPMTSAPPPIT | 371 | Q75N03 | |
| PMTSAPPPITPPPGH | 376 | Q75N03 | |
| MNPPSGPRVPPSPTQ | 1 | Q9UHM6 | |
| AAVPPPAAPIPTQMP | 171 | P36957 | |
| PAAPIPTQMPPVPSP | 176 | P36957 | |
| QMLPSPSPPSFSPPA | 621 | Q86WN1 | |
| VFTMPLLSPSPAPPP | 431 | Q9HAP2 | |
| MSSPGPSQPPAEDPP | 1 | Q7Z449 | |
| LPGPNPSPMSRAPGP | 326 | P0CG12 | |
| PMSPSSHSPEGRPPP | 366 | Q969S8 | |
| AQDMGPGPPDPTEPP | 36 | Q13351 | |
| MAEAGPQAPPPPGTP | 1 | Q16254 | |
| SATAVPPPPPPAMNI | 56 | Q7Z5Q1 | |
| PFSPGPAPPPHMGEL | 591 | Q6Y7W6 | |
| GGPSSPPSDPPAMSP | 571 | O14523 | |
| PPSDPPAMSPGPLDA | 576 | O14523 | |
| APAAPIPPAQGAPSM | 91 | Q8IWX8 | |
| TPTPGPTEMPHPGSP | 136 | I3L273 | |
| PTEMPHPGSPETPKP | 141 | I3L273 | |
| GPTPSPAELPTPPEM | 181 | Q9UF56 | |
| QDPTMPPHPAPNPLT | 691 | O15169 | |
| PSPALPVPSGMQVPP | 31 | Q5VZB9 | |
| PAAPAPEPSASPPMA | 86 | A6NMD0 | |
| PEPSASPPMAPTLFP | 91 | A6NMD0 | |
| PPANPPSGLMNPSLP | 1056 | Q86UU0 | |
| LSHEPPPAMLPSPTP | 1166 | Q86UU0 | |
| PTMGAASSGPLPPPP | 516 | Q96PY5 | |
| ETVQNGPVTPPMPPP | 541 | Q96PY5 | |
| MDDVPAPTPAPAPPA | 1 | Q96SL8 | |
| GDPSPPPPPMSALVP | 31 | Q3KQU3 | |
| DPPPAATPVMPKPSS | 816 | O60307 | |
| MASPRSSGQPGPPPP | 1 | O75899 | |
| APRPPPSSPPLSIMG | 46 | O75899 | |
| PPSPFSMAPQASLPP | 481 | P22681 | |
| LPPSATAPPPPGPMQ | 361 | Q8WUI4 | |
| TAPPPPGPMQPRLEQ | 366 | Q8WUI4 | |
| QPEQLVPGPGPAPMP | 526 | O95479 | |
| PPSMPAPAPAASAPV | 1581 | D6RIA3 | |
| SSQPVPAGMTVPPPP | 206 | Q8IY37 | |
| PAGMTVPPPPAAAPP | 211 | Q8IY37 | |
| PAPTAPQPPGDPLMS | 436 | Q6NYC8 | |
| ASFNPSQPPPGFMPP | 681 | Q9UPN6 | |
| PPPPEPTASSMASAP | 431 | Q5FWE3 | |
| VSPTPAPRNPSDPMP | 1241 | P0C0L4 | |
| PALDSAEHPMPPPPL | 81 | Q8N4N8 | |
| SLRPMPPSPSPGPQV | 246 | E9PI22 | |
| APGPPDHPNQPPMMT | 326 | Q8TB24 | |
| PGPPGPLSQTPPMQR | 556 | Q8N4C8 | |
| PKDMPQPGPPVDISP | 1576 | Q2WGJ9 | |
| PPSPEPPMLAPVAKS | 241 | Q5VWG9 | |
| PAPGPMLVSPAPVPL | 801 | Q5VWG9 | |
| LFPPLSMSAPPPPGA | 706 | Q13275 | |
| APGPEPAPMGAPVPT | 146 | Q7Z572 | |
| PLPPFPGAATGPQPM | 291 | O75157 | |
| LAQPAMSLPPQPGPA | 331 | O75157 | |
| PQPSPPPAVPAGPQM | 21 | Q6ZMB5 | |
| GGRPNEIEPPPPEMP | 306 | Q8NCA5 | |
| PTMPPPETPSEGRQP | 21 | P29590 | |
| APPHPQAPPSMTTPP | 561 | Q9H6K5 | |
| LQVPPSPPASPPMSP | 926 | Q9H6K5 | |
| PLQVPPSPPASPPMS | 956 | Q9H6K5 | |
| PPSPPASLPMSPLAK | 991 | Q9H6K5 | |
| SAMSPIPVGPPSPFP | 41 | Q9HAZ2 | |
| PELMNANPSPPPSPS | 66 | O00141 | |
| PGPPEPVMLPQPTSQ | 236 | P98174 | |
| PPGPEAPRPTPEAMK | 401 | Q8IVL1 | |
| PSPEPPPSVVRFAMP | 1196 | Q13635 | |
| PAVPPAASPVMPPQT | 316 | P51532 | |
| PNSPPSTPVPHSMPP | 311 | Q5T5P2 | |
| PPPSPMPGRIAATPA | 1561 | Q9C0D5 | |
| MQDPSPASLSPPAPP | 181 | Q6ZUB1 | |
| PPGPPPPDTNSMELG | 451 | Q9UPS6 | |
| MPQSQPLPSSPAQPP | 991 | Q9P2R6 | |
| EMANSPQPPPLSPHP | 526 | Q9UHV7 | |
| QTMLPAPVPSPLPSP | 1661 | Q6ZRS2 | |
| MAPAAALPPVPSPPA | 81 | Q9UHV2 | |
| SRLPQPPMPSNFPEP | 306 | Q9NP71 | |
| PSMQPPAPPAELAAP | 541 | Q17R89 | |
| APGTLPPPNLPVSMA | 1126 | Q8TAQ2 | |
| RSPMPPDPPAPPTIQ | 491 | Q96KW2 | |
| SLRPMPPSPSPGPQV | 246 | P0DMB1 | |
| PPETPPPAQMPSAGG | 1521 | Q8IY92 | |
| DPGSPFQMPADTPPP | 211 | Q15797 | |
| APPPPPGSAQPGMAK | 1581 | Q9UPX8 | |
| SSPSPAPAMSPVPPS | 1196 | Q9Y566 | |
| MSSEPPPPPQPPTHQ | 1 | Q9Y2V2 | |
| FPPPSPAPMTQPGPL | 391 | P60852 | |
| NPLVAATSPMPGPPL | 1816 | Q9C0A1 | |
| APEAPPPTLPPDMAQ | 1461 | P04275 | |
| QPPMEAQSLPGAPPP | 66 | Q9UHK0 | |
| AMAPPPPPLAASTPL | 36 | Q9NRA0 | |
| PAPGPAQGPLPMKSP | 416 | Q9BW04 | |
| PPGMPPVTAPGTPAL | 116 | O14776 | |
| PMPTEGTPPPLSGTP | 11 | Q99640 | |
| SPMAPAPAATPEPPA | 991 | Q92766 | |
| LPGSTMTPPPSGPNP | 366 | Q92734 | |
| HPPSTPTMPGNPPGL | 461 | A7XYQ1 | |
| PGAPLPSLPFPPVSM | 481 | A7XYQ1 | |
| VPASETSPGPPPMGP | 51 | Q9HD15 | |
| ELPAPSPMPQLPPDT | 11 | Q8N5L8 | |
| PAAEPPPPPAPDMTF | 86 | Q9Y2X9 | |
| PPPPPPAMTNEAGAP | 66 | Q9NTJ3 | |
| DGMPGSPPPSQPDPE | 481 | O94885 | |
| GPPSPPAPVMHSPSR | 221 | Q13573 | |
| MPPAEKSEGPPVPAP | 1 | A0A0U1RQS6 | |
| PGMPPSLSSAGPPPV | 576 | P49750 | |
| SSTAPPPVMPLPPLS | 611 | P49750 | |
| MEAAPGTPPPPPSES | 1 | Q9UPT8 | |
| PSSPLPGNPTPPMTP | 366 | Q8NF64 | |
| VFPPAMPPPATHLSP | 101 | Q9C026 | |
| MEQSPPPAPEPTQGP | 1 | Q96AY4 | |
| MAPPSAPLPAQGPGK | 1 | Q96CS4 | |
| HPPMSPSALNPPAPT | 281 | Q8WVZ1 | |
| PPPSPGIFPPSVNMV | 1441 | O60346 | |
| MDTPSPDPLPSPLPG | 1 | Q96C55 | |
| FAPVLPPPSTPMPTG | 706 | Q9Y3S1 | |
| SVPPSQIQAPPMPGP | 396 | Q9Y2W2 | |
| TGLPKPHSPMPSPPE | 46 | Q9Y6J3 | |
| MDPQPPPPAQGSPPH | 1 | Q8NAF0 | |
| PEMAPSSAPPSTPPT | 681 | P40818 | |
| DPPPQMAPEIQPPSH | 31 | Q70J99 | |
| PATVPMAPGPPSVFP | 541 | Q96J92 | |
| MAPGPPSVFPPEPEE | 546 | Q96J92 | |
| PAAPANNPPPPSLMS | 346 | Q15637 | |
| QPPPPPPPSSSMASS | 506 | Q15637 | |
| DPAPPSQTPSPPPMA | 306 | O94842 | |
| PPPMATVDPASPAPA | 316 | O94842 | |
| PGPMEPPVSGPDVPS | 201 | Q969T9 | |
| SGGISPPPPITPPSM | 591 | Q14003 | |
| PPPPITPPSMGVTVA | 596 | Q14003 | |
| TPSPKGAPMPPAATP | 1096 | E9PAV3 | |
| GAPMPPAATPPSPKG | 1101 | E9PAV3 | |
| MAEVPPGPSSLLPPP | 1 | Q147X3 | |
| RPSPASQPFMPIGPP | 856 | Q14896 | |
| PTPEPGPKTPPRTMQ | 161 | P28698 |